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Resumo 
 
A obesidade foi classificada pela Organização Mundial de Saúde no top 10 dos maiores 
riscos de saúde no mundo. Esta condição médica é um sério fator de risco para o 
desenvolvimento de diabetes de tipo 2, hipertensão, doenças cardiovasculares, esteatose 
hepática, como também de determinados cancros, podendo custar aos países cerca de mil 
milhões de euros anualmente, quer em tratamentos diretos ou indiretos. Para além de 
atingir proporções epidémicas por toda a humanidade, descobertas recentes apontam para 
uma associação entre a obesidade e os químicos ambientais, denominados “químicos 
obesogénicos”, capazes de alterar o metabolismo lipídico e afetar o reino animal em toda 
a sua extensão. Com o objetivo de elucidar o modo de ação destes compostos e avaliar a 
capacidade de misturas ambientais (efluentes de entrada de Estações de Tratamento de 
Águas Residuais) promoverem efeitos obesogénicos, combinamos um ensaio in vivo 
usando a espécie-modelo peixe-zebra (Danio rerio) e avaliações de alterações na 
expressão de genes essenciais para a lipogénese/adipogénese e lipólise, juntamente com 
um ensaio de transativação in vitro, focado na interação dos compostos com os recetores 
nucleares retinoid X receptor α (RXRα), peroxisome proliferator-activated receptor γ 
(PPARγ) e heterodímero RXRα:PPARγ do ser humano e do peixe-zebra. As larvas foram 
alimentadas com uma dieta rica em lípidos durante todo o ensaio e foram expostas, desde 
a sua saída do ovo até ao dia 18 pós-fertilização, aos seguintes tratamentos: Controlo, 
controlo solvente (DMSO), 100 ng/L e 200 ng/L Sn do composto obesogénico modelo, 
tributilestanho (TBT), 1.25% e 2.5% de efluente de entrada de ETAR. Um acréscimo 
significativo na acumulação lipídica foi detetado em todos os tratamentos com TBT e 
efluente de ETAR, com a exceção do efluente a 1.25%, enquanto a expressão de genes 
aumentou significativamente para todos os genes lipogénicos/adipogénicos em ambas as 
concentrações de efluente de ETAR. Os tratamentos com TBT não exibiam alterações na 
expressão génica, exceto em FASn na concentração de 100 ng/L Sn. Os resultados da 
transativação indicaram uma ativação significativa do heterodímero humano e repressão 
do heterodímero de peixe-zebra no tratamento com 250 nM de TBT, enquanto o efluente 
a 10% ativou apenas o heterodímero humano. Em geral, o nosso estudo mostra a 
capacidade de amostras ambientais e compostos obesogénicos causarem a disrupção da 
homeostasia lipídica através da interação com os recetores RXRα e/ou PPARγ, 
promovendo a obesidade enquanto alteram a expressão de genes e enzimas “chave” das 
vias reguladas por estes recetores nucleares.  
Palavras-chave: obesidade, químicos obesogénicos, disruptores endócrinos, receptor 
nuclear, adipogénese, lipogénese. 
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Abstract 
 
Obesity has been ranked in the top 10 health risks in the world by the World Health 
Organization. This medical condition is a serious risk factor for the development of type-2 
diabetes, hypertension, cardiovascular disease, hepatic steatosis, as well as some cancers, 
and can cost countries billions of euros annually in direct or indirect care. Besides reaching 
epidemic proportions in human beings all around the world, recent findings point to an 
association between obesity and environmental chemicals, named “obesogens”, able to 
alter lipid metabolism and thoroughly affect the animal Kingdom. Aiming to elucidate the 
mode of obesogen action and assess the ability of environmental mixtures (WWTP influent) 
to promote obesogenic effects, we have combined an in vivo assay using the model species 
zebrafish (Danio rerio), and evaluations of the altered expression of key genes involved in 
lipogenesis/adipogenesis and lipolysis, with an in vitro transactivation assay with human 
and zebrafish nuclear receptors retinoid X receptor α (RXRα), peroxisome proliferator-
activated receptor γ (PPARγ) and the RXRα:PPARγ heterodimer. The zebrafish larvae were 
fed with a high fat diet throughout the experiment and exposed from hatching to the 18th 
day postfertilization to the following treatments: Control, Solvent control (DMSO), 100 ng/L 
and 200 ng/L Sn of model obesogen tributyltin (TBT), 1.25% and 2.5% of WWTP influent. 
A significant increase in lipid accumulation was detected in all exposure treatments except 
for 1.25% influent, whereas gene expression was enhanced for all lipogenic/adipogenic 
genes in both WWTP treatments. TBT treatments did not exhibit changes in gene 
expression, with the exception of FASn at 100 ng/L Sn TBT. Transactivation results 
indicated a significant activation of the human heterodimer and repression of the zebrafish 
heterodimer in the treatment with 250 nM TBT, while WWTP influent at 10% activated the 
human heterodimer. In general, our study demonstrates the ability of environmental 
samples and a model obesogen to cause the disruption of lipid homeostasis through 
interaction with the RXR and/or PPARγ receptors, therefore promoting obesity whilst 
modulating the expression of key genes from downstream pathways. 
Keywords: obesity, obesogens, endocrine disruptors, nuclear receptor, adipogenesis, 
lipogenesis. 
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1. Introduction 
1.1. The obesity epidemic 
Obesity, also known as adiposity, is characterized by an abnormal accumulation of fat 
and increased amount and size of fat cells in the body that may result in the impairment of 
health, not only in adults but also in adolescents and young children (Chamorro-Garcia & 
Blumberg, 2014; Grün & Blumberg, 2009; Landgraf et al., 2017; Newbold et al., 2007). Its 
prevalence, as well as the ones of its associated diseases, is reaching epidemic proportions 
all around the globe, affecting primarily industrialized and western countries, such as the 
United States (Grün & Blumberg, 2009; Minchin & Rawls, 2011; Newbold et al., 2007; 
Santos et al., 2012). Consequently, obesity has been ranked as one of the top 10 health 
risks in the world, by the World Health Organization, as it is estimated that the number of 
people with excessive weight is currently larger than the number of undernourished people 
in the world (Newbold et al., 2007). This medical condition can cost countries billions of 
dollars per annum in either direct or indirect care (estimates for the USA: $147 billion in 
2008, equivalent to around 128.8 billion €) (Spencer & Tilbrook, 2011). 
Obesity is a serious risk factor for the development of metabolic syndrome-associated 
disorders (dyslipidemias), type-2 diabetes, hypertension, cardiovascular disease, 
nonalcoholic fatty liver disease (also known as hepatic steatosis), asthma and pulmonary 
problems, osteoarthritis, gall bladder and kidney disease premature mortality and some 
cancers as well (Grün & Blumberg, 2009; Landgraf et al., 2017; Minchin & Rawls, 2011; 
Newbold et al., 2007). Furthermore, weight disruption has been linked to psychological 
problems, such as poor self-esteem, depression and social discrimination (Newbold et al., 
2007) and also neurological disorders such as schizophrenia and bipolar disorder, besides 
being a side effect of the use of pharmaceutical treatments designed to treat these disorders 
(atypical antipsychotics, tricyclic antidepressants and selective serotonin reuptake inhibitor 
antidepressants) (Grün & Blumberg, 2009). 
Even though this medical condition develops primarily from a chronic positive energy 
balance, which means that energy intake exceeds energy expenditure (Grün & Blumberg, 
2009; Minchin & Rawls, 2011), its exact causes are still uncertain (Newbold et al., 2007; 
Santos et al. 2012). In fact, there are several factors regulating fat accumulation and 
distribution, as well as the mobilization of lipids from adipose tissue, which do not result only 
from overeating and exercise (Grün & Blumberg, 2009), as this condition is thought to be 
caused by a complex interaction between genetic, behavioral and environmental factors 
(Newbold et al., 2007; Spencer & Tilbrook, 2011). Hence, the existence of single nucleotide 
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polymorphisms in some genes and genetic heritage, the exposure to viruses, the conditions 
of the intestinal microbiome, psychological stress and chronic reductions of sleep, can also 
influence obesity (Bašić et al., 2012; Chamorro-Garcia & Blumberg, 2014; Grün & 
Blumberg, 2009; Santos et al., 2012; Spencer & Tilbrook, 2011). In fact, although body fat 
distribution is heritable in mammals, which suggests that different adipose depots have their 
own unique developmental gene expression signature, these also respond differently to 
nutritional status (Birsoy et al., 2013). 
Furthermore, recent findings seem to point out the existence of a new factor influencing 
obesity: chemical exposure. These chemicals, known as “obesogens”, which can be natural 
or xenobiotic (Janesick & Blumberg, 2011), are able to alter lipid homeostasis directly 
through stimulation of adipogenesis and fat accumulation, or indirectly through regulation 
of appetite and satiety (Chamorro-Garcia & Blumberg, 2014; Grün & Blumberg, 2009; 
Janesick & Blumberg, 2011; Newbold et al., 2007; Santos et al., 2012).  They can possibly 
explain the rapid increase in obesity rates that coincided with the augmented release of 
industrial chemicals in the past four decades (Newbold et al., 2007; Santos et al., 2012). 
1.2. Lipid homeostasis 
Lipid homeostasis is crucial to ensure the energy balance of organisms but also for the 
proper functioning of cells (Santos et al., 2012). Owing to their variety in chemical properties, 
lipids are able to participate in a diversity of functions within the cell and in the whole 
organism. They play essential roles in the energy storage (triacylglycerol and cholesterol 
ester), are part of the structure of biological membranes (phospholipids and sterols) and 
can be used as intracellular messengers, enzyme cofactors, electron carriers, light-
absorbing pigments, hydrophobic anchors for proteins, hormones, “chaperones” to help 
membrane proteins fold and also as precursors for biosynthesis (Baeza-Jiménez et al., 
2014; Birsoy et al., 2013). 
All animals have developed mechanisms to maintain energy reserves and store fat in 
order to survive periods where food is scarce (Birsoy et al., 2013; Santos et al., 2012).   
Several different body organs contribute to the maintenance of the energy homeostasis. 
The central nervous system plays an essential role as a coordinator of all processes 
involved in the homeostasis, as it acts as a lipid and hormone sensor and integrates afferent 
information from different organs, transforming it into signals that will ensure the necessary 
adjustments, for example, through a change in feeding behavior or energy expenditure 
(Lyssimachou et al., 2015; Santos et al., 2012). The muscle is the main organ involved in 
energy expenditure and lipid oxidation (Lyssimachou et al., 2015). The liver plays a central 
role in glucose and fatty acids synthesis, metabolism and distribution. Due to the liver’s 
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short capacity to accumulate fat, it is a good indicator of diseases such as the non-alcoholic 
fatty liver, hepatocyte apoptosis and hepatic steatosis (Lyssimachou et al., 2015). Moreover, 
most obesogenic compounds have the liver as the primary target organ (Maradonna et al., 
2015). In the mammalian liver, fatty acid synthesis begins in the cytosol with the conversion 
of acetyl-CoA into malonyl-CoA by acetyl-CoA carboxylase (ACC), followed by the 
synthesis of fatty acids catalyzed by the fatty acid synthase complex (FAS), which converts 
malonyl-CoA into a palmitate (Guan et al., 2016; Kersten et al., 2001, Santos et al., 2012). 
Finally, triglycerides are formed from the esterification of the palmitate molecule (Guan et 
al., 2016; Kersten et al., 2001). 
Lipogenesis includes the synthesis of fatty acids and subsequent triglyceride synthesis 
and can occur in both the liver and the adipose tissue (Kersten, 2001). De novo lipogenesis 
is the process through which carbohydrates and protein from the diet are transformed into 
fat and occurs due to the inexistence of a mechanism for direct storage of a long-term supply 
of these nutrients (Santos et al., 2012). Excess energy is stored in the form of triglycerides 
in the adipose tissue, until it is converted to fatty acids and released into the blood stream 
when energy sources are low (Lyssimachou et al., 2015; Moseti et al., 2016). After a 
prolonged positive energy balance, it is possible for triglycerides to be stored in the muscle 
and liver as well, which can potentially lead to metabolic disorders (Lyssimachou et al., 
2015). Moreover, while fat accumulation in the subcutaneous adipose tissue is considered 
an adaptive process, exceeding its storage capacity diverts the excess of fatty acids 
towards the accumulation in the visceral cavity, which, on the contrary, is associated to 
adverse health consequences (Chamorro-Garcia & Blumberg, 2014). 
In Metazoans, lipid accumulation occurs in specific cell types, in contrast to vertebrates 
that own a whole tissue dedicated to lipid storage: the adipose tissue (Birsoy et al., 2013). 
Around 50 to 60% of the mammalian adipose tissue is composed of adipocytes, with the 
remaining cells types being endothelial cells, pericytes, fibroblasts, leukocytes, neurons and 
preadipocytes (Birsoy et al., 2013). This tissue functions as an active endocrine and 
immune organ, secreting pro- and anti-inflammatory adipokines (e.g. leptin, resistin and 
adiponectin) in abundance that regulate metabolic processes by acting on the central 
nervous system and peripheral tissues involved in adiposity, glucose homeostasis, food 
intake and lipid metabolism, among other processes (Bašić et al., 2012; Birsoy et al., 2013; 
Santos et al., 2012). 
The process by which precursor stem cells (preadipocytes) differentiate into lipid-loaded 
mature adipocytes, adipogenesis, is controlled by a complex gene expression program 
(Moseti et al., 2016; Kersten, 2001) and comprises two stages: the commitment of stem 
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cells into adipocyte precursors and the terminal differentiation of preadipocytes into mature 
fat cells (Birsoy et al., 2013). In vitro studies with embryonic stem cells, mesenchymal stem 
cells (MSC) and 3T3L1 fibroblasts (preadipocytes) are the most common for the 
identification of key regulators of this process: among others, CCAAT/enhancer-binding 
protein (C/EBP) β, C/EBPδ and sterol regulatory element-binding protein (SREBP-1) as 
early regulators of adipogenesis, peroxisome proliferator-activated receptor γ (PPARγ) and 
C/EBPα for the final adipocyte maturation where they will modulate the expression of other 
adipocyte-specific genes (Birsoy et al., 2013; Moseti et al., 2016; Santos et al., 2012). The 
fatty acid binding protein 4 (FABP4), adiponectin, and fatty acid synthase (FAS) are needed 
for the maturation of adipocytes (Moseti et al., 2016). 
The distribution of the adipose tissue varies across vertebrates. In fish, amphibian and 
reptiles, the tissue is located mainly in intra-abdominal regions and rarely in the 
subcutaneous area, while in mammals it is distributed throughout the body (Birsoy et al., 
2013). In lower exothermic animals, the tissue is usually small since the lipid storage is 
mainly performed by the liver, which also secretes adiponectin and leptin, the mammalian 
orthologues of the adipokines (Birsoy et al., 2013). 
Other important factors for the maintenance of normal adipose tissue and its functions 
are androgens and estrogens (Grün & Blumberg, 2007). Sex hormones, alongside with the 
growth hormone, counteract the effects of cortisol and insulin by mobilizing the fat instead 
of accumulating it (Grün & Blumberg, 2007; Grün & Blumberg, 2009), and are required to 
regulate adipocyte hypertrophy and hyperplasia (Grün & Blumberg, 2009). Furthermore, 
different levels and ratios of sex steroids are associated with variations in adipose mass 
volume and distribution, as women tend to have a greater body weight, as well as a greater 
number and size of adipocytes, distributed mostly subcutaneously around puberty, followed 
by distribution in the abdominal area during menopause, which is provoked by the lower 
estrogen level and changes in estrogen-androgen ratio (Birsoy et al., 2013; Grün & 
Blumberg, 2007; Yoon, 2009). The lower levels of estrogen in both ovariectomized animals 
and post-menopausal women are also associated, besides the increase in body weight and 
adipose mass, to increased food intake, since when given estrogen these symptoms are 
not displayed (Yoon, 2009). 
Aside from steroid hormones, many other hormone systems are involved in weight 
control (e.g. catecholamines, thyroid hormones, insulin, growth hormone and leptin) and 
are also targeted by environmental chemicals (Bašić et al., 2012; Santos et al., 2012). 
Moreover, the sympathetic nervous system contributes to the control of body weight and fat 
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accumulation through the production of noradrenaline, dopamine and adrenaline (Santos 
et al., 2012). 
Hormones can either have an inhibiting effect (growth hormone and leptin) of stimulating 
effect (insulin) on lipogenesis (Kersten, 2001). The most well-known hormonal factor 
regulating lipogenesis is insulin, which increases the recruitment of glucose transporters to 
the plasma membrane thereby increasing the uptake of this nutrient, but also activates and 
stimulates the expression of lipogenic and glycolytic enzymes, thus stimulating lipogenesis 
(Kersten, 2001). The growth hormone promotes fat loss in the adipose tissue coupled with 
a gain of muscle mass, due to down-regulation of the expression of lipid synthesis genes 
(such as fatty acid synthase) and thus, reduced lipogenesis, either directly or through the 
decrease in insulin sensitivity (Kersten, 2001). 
Leptin is an important adipokine produced by mature adipocytes, as its expression 
highly correlated with the amount of fat mass (degree of adiposity) (Birsoy et al., 2013; 
Kersten, 2001). As the levels of leptin increase, it sends an afferent signal to the 
hypothalamus to decrease food intake, increase energy expenditure and inhibit lipogenesis 
through down-regulation of the expression of genes involved in fatty acid and triglyceride 
synthesis, in order to maintain the homeostasis (Birsoy et al., 2013; Kersten, 2001). In fish, 
leptin is also expressed in the liver, biliary system and intestine (Birsoy et al., 2013). 
Insulin, glucose and leptin all seem to interact either positively (insulin and glucose) or 
negatively (leptin) with the Sterol Regulatory Element Binding Protein-1 (SREBP1), an 
important transcription factor that stimulates lipogenesis when activated (Kersten, 2001). 
This transcription factor mediates most of the effects of nutrients and hormones on the 
expression of lipogenic genes in the liver, while the same occurs through PPARγ in the 
adipose tissue (Kersten, 2001). 
Diets with high carbohydrate content stimulate lipogenesis in both liver and adipose 
tissue, leading to elevated postprandial plasma triglyceride levels, while polyunsaturated 
fatty acids and fasting decrease lipogenesis, respectively, by suppressing gene expression 
in the liver (for example, of fatty acid synthase) and increasing the rate of lipolysis that will 
cause loss of triglycerides from the adipose tissue and increase in plasma-free fatty acids 
(Kersten, 2001).  
Another factor of impact on the pathophysiology of obesity is psychological stress 
(Lyssimachou et al., 2015; Spencer & Tilbrook, 2011). Stressful events cause a significantly 
faster weight gain that is associated with a dysfunctional regulation of the hypothalamic-
pituitary-adrenal (HPA) axis due to higher basal cortisol levels (Grün & Blumberg, 2009; 
Lyssimachou et al., 2015; Spencer & Tilbrook, 2011). The HPA axis is the key endocrine 
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axis that mediates the body’s response to stress. In the presence of a stressor, cells of the 
hypothalamus are activated and stimulate the release of corticotropin-releasing hormone 
(CRH) and arginine vasopressin into the hypothalamohypophysial portal blood vessel 
system, thus releasing adrenocorticotropic hormone from the anterior pituitary into the 
systemic circulation that will stimulate glucocorticoid (cortisol in humans, corticosterone in 
rodents) synthesis at the adrenal cortex.  Right after an acutely stressful event, the appetite 
will be suppressed at the brain level (through CRH) and be followed by an increase in 
appetite and feeding in the subsequent hours to days, which is tied to a peak in 
glucocorticoid release (Spencer & Tilbrook, 2011). It seems that this phenomenon is an 
adaptive solution to replace the loss of energy after an acute episode of stress, but also to 
prepare the body for a possible future stressful event, which raises concern if the stressor 
continues for too long or if there are multiple consecutive stressors, as the chronic increase 
in glucocorticoid levels can lead to a chronic stimulation of appetite (especially for high-
energy foods) and as a result, obesity (Grün & Blumberg, 2009; Spencer & Tilbrook, 2011). 
Glucocorticoids also play a role in adipocyte differentiation and in lipid homeostasis, as 
they enhance lipolysis (through activation of hormone-sensitive lipase) and promote fat 
storage (by enhancing adipose lipoprotein lipase activity), besides enhancing the appetite-
stimulatory effects of ghrelin and reducing the brain’s sensitivity to insulin and leptin, thus 
decreasing their ability to inhibit feeding-stimulatory pathways (Grün & Blumberg, 2009; 
Spencer & Tilbrook, 2011). 
To sum up, both adipogenesis and lipid synthesis and accumulation involve complex 
transcriptional cascades, with cross-talks between many different signaling pathways, in 
which transcription factors are responsible for the expression of key enzymes involved in 
these processes (Moseti et al., 2016; Santos et al., 2012). 
With so many factors influencing this disease, such as the hormonal regulation, 
regulation of glucose levels and the number, size and metabolic activity of adipocytes (Grün 
& Blumberg, 2009; Santos et al., 2012), it is understandable that drugs have been 
developed to act at different levels: to decrease appetite and food intake, to increase energy 
expenditure and to regulate the metabolism and nutrient partitioning (Yoon, 2009). 
1.3. The peroxisome proliferator- activated receptors 
Peroxisome proliferator-activated receptors (PPARs), such as PPARγ, PPARα and 
PPARβ/δ are members of the ligand-activated transcription factors from the nuclear 
receptor (NR) superfamily and have been intensively investigated in mammalians (Santos 
et al., 2012; Yoon, 2009). These receptors play essential roles in adipocyte differentiation 
and in the maintenance of lipid homeostasis, by forming an obligate heterodimer with the 
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retinoid X receptors (RXRs) and acting on DNA response elements in order to change the 
transcription of target genes (Santos et al., 2012). 
In the absence of a ligand, co-repressors are bound to nuclear receptors and chromatin 
is condensed, thus not allowing significant transcription of target genes (Janesick & 
Blumberg, 2011). In contrast, the binding of a ligand causes a conformational change in the 
receptor that will recruit co-activators and lead to the release of co-repressors, as well as 
the decondensation of the chromatin, to induce transcriptional activation (Janesick & 
Blumberg, 2011; Yoon, 2009).  Interestingly, nuclear receptors can also be activated or 
unrepressed through post-translational modifications (PTMs) that cause active release of 
co-repressors in the absence of the NR ligands (Janesick & Blumberg, 2011). 
Mammals have the three PPAR subtypes aforementioned, while teleost fish (e.g. 
zebrafish) may have up to five different PPAR genes (Santos et al., 2012). Each subtype 
has different ligand specificity, tissue distributions and biological functions (Santos et al., 
2012; Yoon, 2009). Yet, as their natural ligands in mammals are fatty acids and lipid-derived 
substrates (Kersten, 2001; Santos et al., 2012), they act as lipid sensors and integrate the 
control of energy homeostasis, lipid and glucose metabolism (Santos et al., 2012). 
The PPARγ is possibly the most important nuclear receptor involved in lipid homeostasis 
and adipogenesis. It is mostly expressed in adipocytes and is required in a variety of 
physiological processes, for example, adipogenic differentiation, inflammation and glucose 
metabolism (Moseti et al., 2016), since it directly induces many genes that regulate the 
adipogenic cascade and lipid uptake, synthesis and storage (Birsoy et al., 2013). In fact, 
this nuclear receptor is widely known as the “Master regulator of adipogenesis” (Birsoy et 
al., 2013; Janesick & Blumberg, 2011; Lyssimachou et al., 2015; Santos et al., 2012), as it 
is massively induced during adipocyte differentiation (Moseti et al., 2016) and amongst the 
several transcription factors involved in adipocyte maturation, only PPARγ is truly necessary 
for adipogenesis (Santos et al., 2012). 
Even though PPARγ activation is a necessary condition for the differentiation of 
preadipocytes into adipocytes, simply testing the activation of this receptor by a chemical 
was shown not to be enough to predict the obesogenic potential of the latter (Janesick & 
Blumberg, 2011), as other mechanisms of action are equally important for this purpose 
(Pereira-Fernandes et al., 2013). 
Several compounds have been shown to be agonists of this nuclear receptor in reporter 
gene assays, yet have not been linked to obesity. Moreover, some compounds might 
activate the receptor in some types of cells but not in others, as the recruitment of 
coregulators to PPAR target genes is variable (Janesick & Blumberg, 2011). A particularly 
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contradictory example is mycophenolic acid, a PPARγ-agonist in 3T3-L1 preadipocytes, 
that was shown to inhibit the adipogenesis in the same cells (Ubakata et al., 2007). In 3T3-
L1 cells, it was also shown that this NR can function as an unliganded receptor or that it 
might be activated by endogenous ligands (Walkey & Spiegelman, 2008). 
The PPARγ:RXR heterodimer increases the expression of genes that exert different 
functions in distinct body organs (Santos et al., 2012): 
 ¾  Adipose tissue: energy expenditure, fatty acid storage, glucose uptake, 
adipocyte differentiation and increase or decrease of adipokines. 
 ¾  Muscle: glucose uptake and glucose oxidation. 
 ¾  Liver: energy expenditure, fatty acid uptake and gluconeogenesis. 
 ¾  Macrophage: cholesterol efflux and lipid uptake. 
 ¾  Pancreas: β-cell function. 
Besides fatty acids, prostaglandins have also been suggested as natural ligands of 
PPARγ (Birsoy et al., 2013). 
The PPARγ is known to be sensitive to environmental chemicals (Janesick & Blumberg, 
2011; Lyssimachou et al., 2015), as its ligand-binding pocket is large enough to accept a 
variety of chemical structures (Janesick & Blumberg, 2011). Consequently, the existence of 
chemicals, such as endocrine disrupting chemicals (EDCs), that are able to interfere with 
these receptors pose a concern, as they might lead to the disruption of the homeostasis 
due to inappropriate regulation of the pathways (Santos et al., 2012). Moreover, the 
obligatory PPARγ:RXR heterodimer is permissive, which means that it is possible to target 
either half of the heterodimer, as the signaling can be mediated by ligand activation of either 
half (Grün & Blumberg, 2009). 
Another reason for concern is that, while PPARs are present in vertebrates and several 
invertebrate groups, RXR is common within metazoans and consequently, the disruption of 
these pathways through RXR might have a wider taxonomic scope than expected (Santos 
et al., 2012; Lyssimachou et al., 2015). 
PPARα plays a central role in lipid and lipoprotein metabolism and regulates energy 
balance by promoting fat catabolism, decreasing dyslipidemia associated with metabolic 
syndrome (Yoon, 2009). It also promotes ketone body synthesis and glucose sparing 
(Santos et al., 2012). Its expression is particularly high in tissues like the liver, heart, muscle, 
brown adipose tissue, skeletal muscle, kidney and intestinal mucosa, where the levels of 
mitochondrial and peroxisomal fatty acid catabolism are greater (Yoon, 2009). Natural 
ligands for this receptor are fatty acids and derivatives, yet it can also be activated by 
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synthetic compounds, such as, nonsteroidal anti-inflammatory drugs, carbaprotacyclin, 
pirinixic acid, phthalate ester plasticizers and hypolipidemic drug fibrates used to decrease 
the levels of circulating triglycerides and increase high-density lipoprotein cholesterol levels 
(Yoon, 2009). 
PPARα suppresses the expression of acetyl-CoA carboxylase (ACC), which is the 
enzyme responsible for de novo lipogenesis and thus the reduction of its activity decreases 
the levels of intracellular fatty acids available for triglyceride synthesis. Moreover, inhibitors 
of ACC also enhance the oxidation of fatty acids, increasing energy expenditure in 
experimental animal and cultured cells (Yoon, 2009). Among other target genes of PPARα, 
fatty acid synthase (FAS) gene expression is also decreased, while the gene expression of 
Acyl-CoA oxidase (ACOX), an enzyme involved in peroxisomal β-oxidation, is increased by 
PPARα activation (Grün & Blumberg, 2009; Yoon, 2009). 
To further complicate the mechanisms underlying obesity, even though both 
estrogens and PPARα exert anti-obesogenic effects, it appears that PPARα ligands only 
function as efficient controllers of obesity when the levels of estrogen are low (e.g. in men 
and postmenopausal women). There is a bidirectional signal cross-talk regulation between 
PPAR and Estrogen Receptor (ER), as they compete not only directly for DNA binding in 
the response elements, due to sequences that can be recognized by both receptors, but 
also for coactivators, availability of corepressors and other mechanisms. Consequently, 
PPARα ligands, such as fenofibrate, may be ineffective in treating lipid disorders in 
premenopausal women, since PPARα activity is inhibited in the presence of estrogen 
(Yoon, 2009). 
Finally, PPARβ does not have a specific tissue distribution but also regulates fatty 
acid oxidation in the tissues where PPARα is either absent of less expressed (Santos et al., 
2012). 
Regardless, developing anti-obesity therapies that promote weight loss and 
increase fat oxidation, for example, by targeting the PPARα, seems to be a good alternative 
strategy to the long-term use of drugs, such as sibutramine and orlistat, which have 
unwanted side effects (Yoon, 2009). 
The factors influencing lipogenesis and/or adipogenesis are summarized in Figure 
1. 
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Figure 1. Scheme listing some of the many factors influencing obesity. 
1.4. Identified obesogens and possible modes of action 
Obesogens are a class of EDCs capable of interfering with the lipid metabolic pathways 
(Lysshimachou et al., 2015). The disruption of the lipid homeostasis by EDCs is an 
emerging new field, as there is increasing evidence of their effects not only in humans but 
also animals such as pets, feral rodents and laboratory animals, living in proximity to human 
populations, that have also suffered weight gain (Chamorro-Garcia & Blumberg, 2014; Grün 
& Blumberg, 2009; Lyssimachou et al., 2015; Newbold et al., 2007). EDCs are known to 
mimic or block the role of natural hormones and interfere with nuclear receptors, 
dysregulating the metabolic pathways and thus, leading to changes in patterns of gene 
expression (Grün & Blumberg, 2007; Lyssimachou et al., 2015; Newbold et al., 2007). Some 
of these chemicals were initially characterized as “androgenic” or “estrogenic”, yet later 
have been found to also interact with nuclear receptors involved in lipid homeostasis 
(Lyssimachou et al., 2015). 
Exposure to chemicals in utero and during early development (critical periods of 
differentiation), can alter developmental programming leading to obesity that might not 
manifest until later in life (Bašić et al., 2012; Grün & Blumberg, 2007; Newbold et al., 2007; 
Santos et al., 2012). Effects of this exposure can sometimes be transgenerational. 
Mesenchymal stem cells are pluripotent cells that can originate a variety of lineages 
(adipogenic, osteogenic and cartilagenic). Thus, if they are under stimuli that bias their fate 
towards the adipocyte lineage, it is possible that the animals are predisposed to possess 
more fat cells than they normally would (Chamorro-Garcia & Blumberg, 2014). 
In regard to general environmental estrogens (e.g. diethylstilbestrol, bisphenol A and 
dichlorodiphenyltrichloroethane, DDT), these seem to promote anti-adipogenic effects in 
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adults, yet some of these compounds can still interact with non-estrogenic signaling 
pathways, resulting in adipogenic effects (Chamorro-Garcia & Blumberg, 2014; Grün & 
Blumberg, 2007). On the other hand, if exposure to estrogens occurs in the prenatal or early 
perinatal period, the effect is expected to be pro-adipogenic (Grün & Blumberg, 2007). 
Phytoestrogens, natural compounds found in soy products, such as genistein and daidzein, 
mimic estrogen action on adipogenesis and lipogenesis (Grün & Blumberg, 2007). 
One possible mode of obesogen action is by targeting the PPARγ at a transcriptional 
level, through the modification of chromatin structure, aiding the expression of PPARγ 
during adipogenesis (Janesick & Blumberg, 2011). With regard to post-translational 
modifications (PTMs), mentioned in the previous subchapter, PPARγ is known to be 
phosphorylated, SUMOylated and ubiquitinated (van Beekum et al., 2009). It has been 
suggested that targeting these PTMs could lead to an obesogenic potential if they stabilize 
the PPARγ protein and increase the transcription of adipogenic genes or regulate the 
receptor’s interactions with the transcriptional machinery (Janesick & Blumberg, 2011). 
It has also been suggested that obesogens could induce epigenetic modifications (e.g. 
altering the methylation patterns of promotor regions of genes or leading to histone 
modifications) in genes that are perhaps involved in the etiology of obesity (Bašić et al., 
2012; Chamorro-Garcia & Blumberg, 2014; Newbold et al., 2007). Moreover, these 
epigenetic modifications might lead to transgenerational changes in gene expression 
(Chamorro-Garcia & Blumberg, 2014). 
Genistein is a phytoestrogen reported to decrease obesity occurrence (Grün & 
Blumberg, 2007; Newbold et al., 2007) by reversing the increase in fat accumulation in a 
gender specific and dose-dependent manner (Grün & Blumberg, 2007). It has been shown 
to increase the methylation of the promotor region of the Avy allele, a gene associated with 
obesity, subsequently leading to its silencing in genetically altered mice that develop obesity 
and thus reverting its phenotype to a normal instead of an obese one (Newbold et al., 2007). 
Therefore, the possibility that chemicals might have a similar mode of action, enhancing 
obesity, should be investigated. 
So far, a few chemicals with obesogenic potential have already been identified: 
organotins (tributyltin, TBT, and triphenyltin, TPhT), thiazolidinediones (TZDs such as 
rosiglitazone and pioglitazone), phthalates (diethylhexylphthalate, DEHP, and mono-(2-
ethylhexyl) tetrabromophthalate, METBP), bisphenol A (BPA) and its derivatives and flame 
retardants such as polybrominated biphenyls (tetrabromobisphenol-a), polychlorinated 
biphenyls (tetrachlorobisphenol-A), organochlorine pesticides, organophosphates, 
carbamates, solvents and heavy metals such as cadmium and lead, estrogenic chemicals 
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such as diethylstilbestrol and phytoestrogens (Biemann et al., 2014; Grün & Blumberg, 
2007; Janesick & Blumberg, 2011; Newbold et al., 2007; Riu et al., 2014; Santos et al., 
2012; Watt & Schlezinger, 2015), but little is known about the mechanisms originating these 
effects and many other potential obesogens remain to be discovered. 
1.4.1 Organotins 
Organotins are a class of persistent organic pollutants with potent biocidal properties 
that favored their use as antifouling agents in ship paints, in the production of food crops as 
pesticides, in industries as fungicides and as slimicides in water systems. Moreover, they 
were also used as wood preservatives and as heat stabilizers in the manufacture of 
polyvinyl chloride plastics (Grün & Blumberg, 2007; Grün & Blumberg, 2009; Lyssimachou 
et al., 2015). Their wide range of applications, made them possible to be detected in house 
dust, in significant levels (Kannan et al., 2010).  
Obesogenic members from this class of xenobiotic chemicals include the tributyltin 
(TBT) and triphenyltin (TPhT) (Santos et al., 2012). Within this class, the masculinizing 
effects of TBT became famous for causing the irreversible phenomena called “imposex”, 
characterized by the induction of male characteristics in female marine gastropods (Castro 
et al., 2007). Due to its high toxicity towards many aquatic organisms and being a chemical 
with a tendency to be bioaccumulated, the use of TBT as an antifouling agent in paints was 
prohibited in 2008 (Lyssimachou et al., 2015). Regardless, it is still found near ports in water 
samples and sediment at concentrations of 200-400 ng/L and 1-10 ng/L, respectively, as its 
low solubility and high octanol-water partition coefficient make this contaminant more 
persistent in the environment (Lyssimachou et al., 2015). In 2006, Rodríguez-González and 
his colleagues reported levels of TBT of 1.966 µg/L in a port on the North West coast of 
Spain, Bay of Gijón (Rodríguez-González et al., 2006), which is concerning since 
concentrations of TBT of 1 ng/L have been reported to be enough to cause toxicity in several 
marine species (Lyssimachou et al., 2015; Rodríguez-González et al., 2006). 
The most frequent sources of organotins in general are contaminated drinking water, 
agricultural products and seafood (Chamorro-Garcia & Blumberg, 2014; Bašić et al., 2012), 
resulting in measured levels of TBT, in human tissues and blood, from 0.5 nM to 27 nM, 
while marine mammals that bioaccumulate persistent organic pollutants reach levels of 
around 7 µM daily (Grün & Blumberg, 2009). 
TBT was the first obesogen having his mechanism of action clarified (Janesick & 
Blumberg, 2011). In mammals, TBT is an RXR and PPARγ agonist and the activation of the 
latter is required for the obesogenic effects of this chemical (Janesick & Blumberg, 2011; 
Santos et al., 2012). TPhT is also a high-affinity ligand of both RXRs (α, β, γ) and PPARγ, 
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and like TBT, it promotes the expression of adipocyte marker genes in vitro (Grün & 
Blumberg, 2009; Santos et al., 2012). In fact, several in vivo studies report the disruption in 
the lipid metabolism in many tissues after exposure to these chemicals, not only in 
mammals but also in amphibians, teleost fish and some invertebrates (Santos et al., 2012). 
Chamorro-Garcia and collaborators reported some transgenerational effects that in utero 
exposure to low doses of TBT has on the increase of adipose tissue in three generations of 
mice (Chamorro-Garcia et al., 2013). TBT alters the fate of stem cells and directs them to 
differentiate into adipocytes (Bašić et al., 2012). 
Interestingly, organotins appear to have multiple modes of action. Another molecular 
target of organotins is the enzyme that is necessary for the conversion of androgens to 
estrogens, aromatase cytochrome p450, through which these chemicals inhibit the 
production of estradiol, thus disturbing the levels and ratios of sex steroids (Grün & 
Blumberg, 2007; Rodríguez-González et al., 2006), which could also lead to an adipogenic 
effect. 
Organotins were also shown to interfere with glucocorticoid homeostasis: TBT and 
dibutyltin cause hypercortisolism through inhibition of 11β-hydroxysteroid dehydrogenase 2 
(11β-HSD2) activity, the enzyme responsible for deactivating the cortisol (Grün & Blumberg, 
2009; Lyssimachou et al., 2015). Dibutyltin also acts as a potent antagonist of the 
glucocorticoid receptor (Le Maire et al., 2009). 
1.4.2 Thiazolidinediones 
Thiazolidinediones (TZDs), such as rosiglitazone and pioglitazone, are pharmaceutical 
obesogens used to treat type 2 diabetes mellitus (Janesick & Blumberg, 2011; Santos et 
al., 2012), by improving serum triglycerides and glycemic control (Bašić et al., 2012). These 
synthetic drugs reduce the concentration of plasma glucose by enhancing the sensitivity to 
insulin in patients with low insulin responsiveness, through secretion of adiponectin (an 
insulin-sensitizing adipokine) and consequently increasing glucose uptake (Birsoy et al., 
2013; Moseti et al., 2016). Since TZDs also activate the PPARγ (Moseti et al., 2016; Santos 
et al., 2012), these chemicals have the side-effects of leading to proliferation of adipocytes 
(increase in white adipose tissue, WAT), reduction of adipocyte hypertrophy and 
consequently, weight gain (Grün & Blumberg, 2009; Janesick & Blumberg, 2011; Santos et 
al., 2012). Regardless, in this case, the diversion of calories towards adipose weight gain 
is considered benign, as these drugs help regularize the deleterious blood glucose levels 
of diabetes (Grün & Blumberg, 2009), although possible side-effects of the use for a 
prolonged time include increase risk of cardiovascular diseases and in the case of 
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rosiglitazone, increased risk of acute myocardial infarction, stroke and heart failure (Bašić 
et al., 2012). 
1.4.3 Phthalates and Perfluorooctanoic acid 
Phthalates are organic additives used to increase the flexibility and durability of plastics 
(e.g. polyvinyl chloride) and are broadly used in food packaging, toys, paints, construction 
materials, electronic and medical devices and personal care products and cosmetics 
(Adeogun et al., 2015; Janesick & Blumberg, 2011). 
 It seems that primary phthalates, such as (2-ethylhexyl) phthalate (DEHP), are more 
active on PPARα, while phthalate metabolites, such as mono[2-ethyl-hexyl]phthalate 
(MEHP), are selective activators of PPARγ (Grün & Blumberg, 2009). Consequently, DEHP 
increases fatty acid oxidation and lipid mobilization, while the presence of urinary DEHP 
metabolites, such as MEHP, was associated with increased waist circumference and insulin 
resistance in men in an epidemiological study (Grün & Blumberg, 2009; Stahlhut et al., 
2007). 
Perfluoroalkyl compounds (PFCs) are widely used as surfactants and surface repellents 
in consumer products and, alongside phthalates, they are agonists of PPARs, some with a 
preference for PPARα, as it is the case with perfluorooctanoic acid (PFOA), thus leading to 
lipid mobilization, fatty acid oxidation and adipocyte atrophy (Bašić et al., 2012; Grün & 
Blumberg, 2009). Even though on this basis it would be expected for these chemicals to 
reduce body weight, chronic low levels of PFOA (>5mg/kg body weight) in rodents led to 
increased adipose tissue mass and body weight gain after puberty (Betts, 2007).  
These xenobiotic chemicals are particularly concerning due to their ubiquity in the 
environment (Janesick & Blumberg, 2011). PFCs leach from treated surfaces and primary 
phthalates from plastics, thus exposing the human being. PFC’s concentration values of 0.6 
ppb in drinking water, 148 ppb in surface water and a range of 4 to 133 ppb in edible fish, 
have been reported. Consequently, they can be detected in people serum, human breast 
milk and even babies’ blood and the transmission through breastfeeding has been 
estimated to be around 200 ng/day (Betts, 2007). 
In the environment, phthalates have also been detected in rainwater, surface water, 
treated and untreated wastewater and also sediments (Clara et al., 2010), with reported 
values ranging from 0.2 to 50 µg.L-1 in rivers (Fatoki & Vernon, 1990). The estimated 
average daily intake of DEHP due to transfer to food during processing is of about 160 µg 
per day (Tsumura et al., 2003). Just like PFCs, phthalates can also be detected in human 
blood, urine and breast milk (Adeogun et al., 2015). 
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1.4.4 Diethylstilbestrol 
The endocrine disruptor diethylstilbestrol (DES) is a synthetic estrogen prescribed from 
the 40s through the 70s to pregnant women at risk of miscarriage and also to women with 
low levels of estrogen (Grün & Blumberg, 2007; Newbold et al., 2007). It is still currently 
used in aquaculture to promote growth and to produce female populations of fish, 
contributing to its detection in surface water in a range of 1 to 20 ng/L (Lei et al., 2016).  
Diethylstilbestrol is a particularly interesting case of an estrogenic compound and 
estrogen receptor agonist that unlike other estrogens, can still have pro-adipogenic effects. 
Although it has been associated, in a mouse model and at concentrations of 10–100 μg.kg−1 
maternal body weight per day (prenatal exposure), to a decrease in offspring birth weight 
that was subsequently maintained, postnatal exposure to concentrations of 1 mg.kg−1.day−1, 
in the first 5 days corresponding to the adipocyte differentiation period, resulted in initial 
body weight depression, followed by a “catch-up” growth period at puberty with a 
subsequent increase in adult body weight, alongside a higher percentage of body fat and 
higher levels of serum adipokines and triglycerides (Newbold et al., 2007). These results 
seem to show that the effects of this compound can be either pro- or anti-adipogenic, 
depending on the period of time in which exposure occurs (Grün & Blumberg, 2007).  
1.4.5 Bisphenol A 
Even though bisphenol A (BPA) is also an estrogenic compound, it is applied as a 
monomer in polycarbonate plastic and epoxy resins and is used widely in beverage 
containers, dental composites, sealants and linings of food cans, from where it can 
gradually leach (Bašić et al., 2012; Grün & Blumberg, 2007). Hence, the human being is 
exposed through consumption of contaminated food, beverage and drinking water 
(Makinwa & Uadia, 2015), resulting in its detection in urine and other body fluids such as 
serum (0.2 to 4.4 ng/mL), amniotic fluid (0.2-20 ng/mL), neonatal, placenta and cord blood, 
and also human breast milk (Grün & Blumberg, 2009; Makinwa & Uadia, 2015). 
Bisphenol A is also a widespread chemical, being found in underground water, rivers, 
landfill leachates, as well as air and dust. Reported environmental concentrations around 
the globe range from 1.9 to 3920 ng/L in river waters, 0.05 to 249 ng/L in seawaters, 0.11 
to 10500 ng/g in sediments and 1 to 17400 pg/m3 in the atmosphere (Huang et al., 2012). 
In the presence of insulin, BPA enhances the up-regulation of genes that promote the 
differentiation of 3T3-L1 preadipocytes (Grün & Blumberg, 2009). Prenatal and neonatal 
exposure to BPA, at concentrations similar to those detected in the human serum, led to 
increased body weight in rodents, along with hyperlipidemia and an apparent trend towards 
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increased food intake and decreased exercise (Bašić et al., 2012; Grün & Blumberg, 2009), 
which suggests that BPA interferes with glucocorticoid metabolism, as it is able to bind to 
the glucocorticoid receptor (GR) (Pereira-Fernandes et al., 2013). 
As reviewed by Rancière et al., (2015), many studies in the epidemiological literature 
report a relation between BPA exposure and cardiometabolic disorders such as diabetes, 
hyperglycemia, cardiovascular disease, hypertension, as well as increased weight and 
waist circumference (abdominal obesity) in adults and children (Rancière et al., 2015). 
The mode of action of this chemical is not yet fully understood, as it seems possible that 
the activation of the nuclear estrogen receptor is not the only mechanism mediating these 
effects (Bašić et al., 2012; Grün & Blumberg, 2009). In fact, this chemical was shown to 
interact with thyroid hormone receptors (Bašić et al., 2012) and PPARγ (Pereira-Fernandes 
et al., 2013). 
1.5. Aim of the study 
Understanding the complex network that regulates the lipid homeostasis and 
adipogenesis, as well as elucidating the mode of action of these obesogens and their role 
in the obesity epidemic, are crucial steps for the development of strategies, pharmaceuticals 
and therapies aiming at the alleviation of obesity. 
 For this reason, we have combined molecular and biochemical techniques, as well 
as in vivo assays to aid in filling some gaps found in literature. 
Given the important role of nuclear receptors in obesity, we performed 
transactivation assays using the PPARγ, RXRα and the PPARγ:RXRα heterodimer, in order 
to test whether suspected obesogens were agonists of these receptors. Since in vitro 
assays and the activation of PPARγ:RXR are not enough to fully predict the obesogenic 
potential of a chemical, we have included an in vivo assay with Danio rerio to verify the 
impact of the suspected obesogen on lipid accumulation using Nile Red staining, followed 
by an evaluation of the expression of key lipogenic and adipogenic genes, via quantitative 
real-time Polymerase Chain Reaction (qPCR). These methodologies could help uncover 
prime targets for new drugs. 
Another objective of our study is to evaluate the ability of complex environmental 
mixtures to deregulate metabolic pathways and induce lipid accumulation and 
adipogenesis. Since more than 95% of all toxicological research is focused on the effects 
of single chemicals (Biemann et al., 2014), adding to the fact that chemical influence on 
obesity is an emerging topic in the scientific community, little is known about the impact of 
complex mixtures, and more specifically environmental samples, on obesity and related 
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disorders. In order to allow a more realistic assessment of this impact on animal and human 
health and as real-life exposure occurs more often to a mixture of chemicals with both pro- 
and anti-obesogenic activities, investigating the outcomes of this exposure is essential. For 
this purpose, we assessed the effects of wastewater treatment plants (WWTP) influents 
both in vitro, through transactivation assays and in vivo, using the zebrafish as a model 
species. 
2. Methodology 
2.1. In vivo assay  
2.1.1. Species Selection: Danio rerio 
The zebrafish (Danio rerio), an omnivorous freshwater fish belonging to the cyprinid 
family in the Actinopterygii class, is commonly used as a model vertebrate in a variety of 
toxicological studies (Hölttä-Vuori et al., 2010). Recently, it has been proposed as an 
emerging model also for the study of lipid metabolism and metabolic diseases (Hölttä-Vuori 
et al., 2010; Landgraf et al., 2017). The selection of this model species is justified by a 
number of reasons. 
Even though laboratory rodent studies are significant for the extrapolation of data to 
humans, its restriction by law, higher price and time-consumption (Hill et al., 2005), make 
this model less available. Moreover, the conservation of genes, receptors and molecular 
processes across animal phyla (Hill et al., 2005), as well as the conservation of the 
regulation of energy homeostasis at both the neural and endocrine levels, when compared 
to the human being and the common pathophysiological pathways of diet-induced obesity 
shared with mammals (Birsoy et al., 2013; Hölttä-Vuori et al., 2010; Landgraf et al., 2017), 
are additional justifications to show that the zebrafish model is suitable to represent more 
complex animals. Hence, it is not surprising that this species’ organs and tissues have 
similar structures and functions to those of humans (Landgraf et al., 2017) and that fish are 
able to develop metabolic diseases also reported in humans (e.g.: non-alcoholic fatty liver 
disease and hepatic steatosis) (Lyssimachou et al., 2015). 
Bioassays using zebrafish are simplified due to this species short-life cycle and also due 
to the fact that its ideal breeding and maintenance conditions are known and thus, can be 
induced to breed all year under controlled laboratory conditions (Hill et al., 2005; Soares et 
al., 2009). The zebrafish attains sexual maturation fast (around 100 days) and each pair is 
able to lay 200 to 300 eggs in a single morning, every 5 to 7 days (Hill et al., 2005). 
Moreover, being a species of small size (26 to 38 mm as an adult), it allows an increase 
in sample size at the same time that the housing space is reduced, minimizing the costs of 
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the dosing solutions and experimental chemicals, as well as the disposal of waste (Hill et 
al., 2005). 
Particularly, for our study, the optical clarity of this species is helpful for the screening 
of lipid accumulations stained with a fluorescent dye in very small larvae, without having to 
dissect the animal. Also, given the fact that the zebrafish genome is completely sequenced, 
it is useful for the study of altered gene expression in response to toxic insult, through qPCR 
and genomic screens (e.g. microarrays) (Hill et al., 2005; Veldman & Lin, 2008). 
2.1.2. Animal breeding 
All the steps described in this section were conducted in the facilities of BOGA (Biotério 
dos Organismos Aquáticos – CIIMAR). 
A breeding stock of adult wild-type zebrafish (Danio rerio; Singapore) was kept in an 
aquarium with 250L of capacity filled with dechlorinated aerated water, at a temperature of 
28 ± 1°C, under a photoperiod of 14:10h (light:dark). The fish were fed with commercial diet 
Tetramin (Tetra, Melle, Germany) twice a day. 
In the afternoon before zebrafish breeding, adult wild-type zebrafish (9 females: 9 
males) were placed in cages within a 30L aquarium, under the same water and photoperiod 
conditions as the stock from which the breeders were selected, and were fed once with 
commercial fish diet Tetramin. The cages possess a net bottom cover, covered with glass 
marbles to prevent eggs from being consumed by adults. 
In the subsequent morning, following the collection and cleaning of the eggs, the 
transparent ones were selected and randomly allocated to different experimental aquaria, 
assuming that the transparency was indicative of the viability and fertilization of the eggs. 
2.1.3. Test conditions and water parameters 
The embryos obtained by natural mating were raised in 3L aquaria filled with 
dechlorinated water, at 28 ± 1 °C with a 14L:10D photoperiod. Each aquarium contained a 
total of 80 eggs.  
From hatching (4th day post-fertilization) until the end of the experiment (18th day post-
fertilization), the larvae were exposed to six different treatments under semi-static 
conditions, each set in duplicates: experimental control, solvent control (0.0002% 
dimethylsulfoxide, DMSO), TBT at 100 ng/L Sn and 200 ng/L Sn, and WWTP influent at 
1.25% and 2.5%.  
The TBT test solutions were obtained by successive dilutions of a stock solution 
containing TBT chloride (96%, Sigma-Aldrich) in DMSO (99.9%, Sigma-Aldrich), and were 
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all kept at -20°C until use. Calculations were made in order to ensure that each aquarium, 
with the exception of those from experimental control, had the same DMSO concentration 
as the aquaria from solvent control. 
In order to determine the actual concentrations in the aquaria and the stability of the 
compounds, water samples were collected once during the assay, at the moment right 
before water renewal and about 20 minutes after the contamination of the new water. 
The medium was renewed daily by changing at least two thirds of its volume, while 
retaining the larvae in the aquaria. The cleaning procedures consisted of rubbing the walls 
and syphoning the bottom of the aquaria. 
The ammonia levels were checked weekly at 640 nm (0.3625 ± 0.033 mg/L N and 
0.4375 ± 0.0369 mg/L N for the 1.25% and 2.5% WWTP influent, respectively, and 0.1425 
± 0.0347 mg/L N for all remaining treatments), using Palintest tablets and Palintest 
Photometer 7000se, while the temperature was monitored daily, with individual 
thermometers in each aquarium. Values of mortality were registered daily (total mortality 
below 20% in all aquaria) and the dead larvae/eggs were removed. 
A light aeration was introduced to the aquaria on the 11th day post-fertilization of larvae 
(Figure 2). 
Throughout the whole experiment, care was taken in order to avoid the suffering and 
distress of the animals. 
 
Figure 2. In vivo assay with zebrafish. The aquaria from each treatment were randomly 
allocated to the water baths. All three water baths contained 2 electric resistances (image 
on the right). Each aquarium contained its own aeration system. 
2.1.4. Feeding protocol  
From 5 days post-fertilization (dpf) to 14 pdf, larvae were fed with a standard diet, 
Gemma Micro (Skretting; 59% protein, 14% oil), supplemented with 25% of additional lipids. 
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For the diet preparation, the standard diet was ground to powder and mixed with an 
emulsion of cod liver oil (Fagron) in a mixer to form a homogeneous moist blend. The 
volume of cod liver oil added to the original diet was calculated in order to obtain a dietary 
lipid content of 25% dry matter in the final diet. The blend was pelleted and pellets were 
dried in an oven at 40ºC for 24 h. Dried pellets were crushed and sieved through a battery 
of sieves to obtain food particles with a diameters of 100-200 and 200-400 µm. 
Excluding the period between the 15th and the end of the assay, the zebrafish larvae 
were fed Artemia spp. nauplii (Brine Shrimp Eggs; Ocean Nutrition) every other day (put to 
hatch for 16 hours from the 7th to the 11th day postfertilization and 24 hours on the 13th day). 
For this end, 0.2 grams of Artemia spp. cysts were incubated in a reactor with 1L of warm 
water (1 part of seawater for 4 parts of freshwater at 28 °C) and this quantity was used to 
feed 3 aquaria with 80 larvae each. Aeration was provided to the reactor in order to maintain 
the oxygen levels and to keep cysts suspended in the water column. A bright light was also 
delivered to maximize hatch rates. 
On the 15th and 16th day postfertilization, the larvae were fed lyophilized chicken egg 
yolk (produced at the laboratory in CIIMAR) as a high fat diet, and were finally followed by 
one day of starvation prior to analysis on the 18th day postfertilization. 
The specifications of the feeding regime are summarized in table 1. 
Table 1. Feeding regime throughout the assay. 
   Period (dpf)  
 0 to 4 5 to 11 12 to 14 15 to 16 17 to 18 
Feeding 
type 
not fed 
Gemma 
Micro 100-
200 µm* 
Mixture 
Gemma 
100-200 µm 
and 200-
400 µm* 
lyophilized 
egg yolk 
and 
Gemma 
200-400 µm 
fasting state 
Quantities None 
12 mg (3 
times a day) 
24 mg (100-
200 µm 
twice a day 
and 200-
400 µm 
once) 
egg yolk 40 
mg (once) 
and 
Gemma 24 
mg (twice) 
None 
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* From the 7th day postfertilization, the larvae were also fed every other day with Artemia 
spp. with 16h since eclosion. On the 13th day, the larvae were fed with Artemia spp. with 
24h. 
2.1.5. Nile Red staining 
On the day of the analysis (18th day postfertilization), 10 larvae of similar size (6.55 ± 
0.56 mm) were selected per aquarium and individually incubated with Nile Red (Sigma-
Aldrich) in 3mL-wells plates, for 60 minutes, at 28 °C and in the dark, in order to avoid 
photobleaching. For this, a Nile Red stock solution of 5 mg per mL of acetone (Biochem, 
Chemopharma) was prepared and diluted 1:1000 in dechlorinated water. 
After the incubation, the wells were rinsed twice with dechlorinated water and 
anaesthetized during 30 seconds with Tricaine 1000mg/g (Pharmaq), stock of 168 mg/mL 
diluted 1:1000 in dechlorinated water. 
The larvae were analyzed in water within approximately 2 minutes, under the 
microscope Nikon Eclipse TS100 with a Nikon Intensilight C-HGFI unit, while using a 
fluorescence filter (B-2A: EX: 450-490nm, BA: 520nm). 
All images were captured under the same settings with imaging software NIS-Elements 
D (version 4.13) and saved in high-resolution (1280x960) Joint Photographic Experts Group 
(JPEG) format. The total length, which is the distance from the rostral tip to the tip of the 
longer lobe of the caudal fin, was registered in the examined larvae. 
The fluorescence signals were subsequently determined using ImageJ software 
(National Institutes of Health, http://rsb.info.nih.gov/ij/). The procedure for these adiposity 
recordings begin with the conversion of the images into 8-bit grayscales, followed by the 
measurement of background fluorescence (calculated individually in each image), in areas 
that did not contain any adipocytes. The value of larvae fluorescence was obtained by 
selecting the white adipose tissue and individual adipocytes in the perivisceral area (Figure 
3) with the “polygon selections” tool of the computer program, and subtracting the 
background fluorescence. The values shown in the graph of results, expressed as the 
average fold changes ± standard error of the mean (SEM) of the solvent control group, 
match the values of the Integrated Density (the product of area and mean gray value), 
obtained in the software for each larvae. 
At the end of the bioassay, the remaining zebrafish were euthanized in MS-222 (Ethyl 
3-aminobenzoate methanesulfonate 98%; Sigma-Aldrich) at a concentration of 200 mg/L in 
order to guarantee minimum pain. 20 of these larvae (per aquarium) were then stored in 
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RNAlater (Sigma) for 24h at 4°C and then moved to -80°C, for posterior molecular biology 
determinations. 
 
Figure 3. Zebrafish at the 18th day postfertilization colored with Nile Red dye; A: Perivisceral 
area from which the measurements of WAT and individual adipocytes were taken; B: 
Example of an area for background fluorescence (note: image not converted to 8-bit 
grayscales). 
2.2. Evaluation of gene expression 
2.2.1. RNA extraction and cDNA synthesis 
The total RNA was extracted from each body of zebrafish larvae, separately, while the 
heads were kept in RNAlater at -80°C for future research. 
The RNA extraction was performed using illustraTM RNA spin Mini RNA Isolation kit (GE 
Healthcare), according to the kit’s instructions. For this purpose, samples were firstly 
homogenized and lysed in tubes containing 350 µL of RA1 (lysis buffer) from the kit, 3.5 µL 
of β-Mercaptoethanol (Merck) and 2 beads. The tubes were then homogenized using the 
Precellys®24 lysis & homogenization equipment (Bertin Technologies), for 2 x 10 seconds 
at 6500 rpm.  
At the end of each extraction, the RNA quality was confirmed in a 1% agarose (NZYtech) 
gel, run in 1x of Tris-Acetate-EDTA buffer (TAE 50x; Bio-Rad) for 25 minutes at 100V and 
containing 1µL GelRedTM (Biotium) for visualization of bands under UV light. The 
concentration of this nucleic acid was determined using Gen5™ software and equipment 
Synergy HT Multi-Mode Plate Reader (BioTek), where each sample was read in 2 
replicates. RNA samples were then kept at -80 °C until use. 
For the cDNA synthesis, the iScriptTM cDNA Synthesis (Bio-Rad) kit was used, following 
the kit instructions and 200 ng of RNA was loaded in each reaction tube. The synthesis was 
performed using the TGradient Thermocycler (Biometra), then the cDNA samples were kept 
at -20°C until their use in Real-time PCR. 
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2.2.2. Real-time PCR 
In order to evaluate the expression of target genes involved in lipid homeostasis and 
adipogenesis, fluorescence-base quantitative (real-time) PCR was performed. 
Gene sequences were retrieved from the National Center for Biotechnology Information 
(NCBI) and primers were designed using the Primer-Blast-NCBI tool 
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/). The selected pair of primers was then 
synthesized by STABVIDA (Portugal). The primers and respective conditions are listed in 
table 2. 
Table 2. Primer pair sequences and respective Tannealing used in real-time qPCR analysis. 
Gene 
Genbank access 
number 
Forward primer 
(5´- 3´) 
Reverse primer 
(5´- 3´) 
Tannealing 
(°C) 
RXRα NM_001161551 
ATTCAATGGC´ATCTCC
TG 
GCGGCTTAATATCC
TCTG 
60 
PPARγ NM_131467 
GGTTTCATTACGGCGT
TCAC 
TGGTTCACGTCACT
GGAGAA 
60 
SREBP1 NM_001105129.1 
CAGAGGGTGGGCATG
CTGGC 
ATGTGACGGTGGT
GCCGCTG 
60 
FASn XM_682295 
ATCTGTTCCTGTTCGA
TGGC 
AGCATATCTCGGCT
GACGTT 
62 
ACOX1 BC097101.1 
GCACGGATGTGTGTAC
CGTGC 
GCGTCCAGAGCCC
CTTGACCT 
62 
β-actin NM_181601.3 
ACTGTATTGTCTGGTG
GTAC 
TACTCCTGCTTGCT
AATCC 
60 
 
The expression of reference gene β-actin and target genes PPARγ, RXRα, FASn, 
ACOX1 and SREBP1, individually, was assessed for each body of larvae separately, using 
the Mastercycler ep realplex system (Eppendorf). Each sample was amplified in duplicate 
and loaded into 96-well white MultiplateTM PCR plates (Bio-Rad). Each well contained 10 
µL of reaction volume, corresponding to 1 µL of cDNA (equals 10 ng), 5 µL of IQ TM SYBR® 
Green Supermix (Bio-Rad), 200 nM of each primer and ultrapure water. The reaction was 
performed according to the Taq polymerase’s protocol, which consisted in a two-step real-
time PCR program with an enzyme activation step at 95°C (3 min), followed by a 40-cycles 
amplification starting with a denaturation step at 95°C for 10 seconds, then 
annealing/extension around 60°C (1 min). A melting curve (55-95°C with 0.5°C increment) 
was also generated at the end in order to confirm the specificity of each amplification. The 
products from the PCR reactions were then visualized in a 1% agarose gel, to further check 
whether or not non-specific products were amplified, by the presence of single bands. 
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A standard curve using successive dilutions of cDNA pools from each sample (6 dilution 
step at a dilution factor of 1:5) was created to determine the efficiency of the reactions for 
each gene. Efficiencies between 88-109% were considered acceptable.  
The β-actin reference gene was validated by its stability among the exposure groups 
and controls, verified through one-way ANOVA. 
Since the expression of all genes was evaluated for each fish individually, comparisons 
among genes in the same individual could be achieved. 
The relative quantification of target genes was performed according to the Livak method 
(Livak & Schmittgen, 2001). The relative changes in gene expression of target genes were 
calculated based on the amount of target normalized to β-actin and relative to an internal 
calibrator:  
Amount of target = 2 -ΔΔCt = (2 -(Ctsample-Ctcalibrator)target ) / (2 -(Ctsample-Ctcalibrator)reference) 
The final data were expressed as fold changes of the solvent control group: mean values 
of treatment dividing by the mean value of solvent control group. 
2.3. Transactivation assays 
2.3.1. Preparation of RXRα and PPARγ constructs 
Danio rerio RXRα and PPARγ sequences were collected from the GenBank database 
using accession codes XM_005161184.2 and NM_131467.1, respectively, and primers 
were designed to amplify the portion of the gene correspondent to the Hinge Region (HR) 
plus Ligand Binding Domain (LBD) of each receptor (Table 3), using the Primer 3 
(http://bioinfo.ut.ee/primer3-0.4.0/). Additional oligonucleotides of the recognition sequence 
for the restriction enzymes XbaI and KpnI were also added to the primers. 
Table 3. Primers designed to amplify the HR+LBD of the NRs. The forward primer contains 
the recognition sequence of XbaI, while the reverse primer contains the sequence for KpnI. 
NR Forward Primer (5´- 3´) Reverse Primer (5´- 3´) 
RXRα 
 
ATCGTCTAGACAGCGAGCCAAGGAAC 
GC 
 
AATTGGTACCTTATGTCATTTGGTGTGGA 
GCTT 
PPARγ 
 
ATCGTCTAGACTGGCCGAGTTCTCCAG 
T 
 
AATTGGTACCTTAGTACAGGTCCCGCAT 
GA 
 
The amplification was performed through Rapid Amplification of cDNA Ends (RACE) 
PCR, using Danio rerio cDNA pool as a template for RXRα and Danio rerio liver cDNA for 
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PPARγ. The resulting products were run on a 1% agarose gel and purified using 
NZYGelpure (NZYTech) kit. Each sequence was then digested with the restriction enzymes 
XbaI and KpnI (Promega), for insertion of RXRα and PPARγ in a pBIND vector and for 
insertion of RXRα in a pACT vector, followed by a new purification using the kits 
aforementioned. The T4 DNA Ligase (Promega) was used to insert the DNA into the pBIND 
or pACT vectors, previously digested with the same restriction enzymes and 
dephosphorylated using an alkaline phosphatase (NZYtech) in accordance to the product 
brochure. The constructs were sent to sequence in order to ensure the integrity and 
orientation of each sequence in the expression vector. 
Escherichia coli competent cells (NZY5α, NZYTech) were transformed with the ligation 
product of each reaction. The cells were plated on agar covered with ampicillin (20 µL per 
petri disk), where they were grown in an inverted position for 16h at 37°C, and a colony 
screening, using pBIND primers or pACT primers and NZYTaq 2× Green Master Mix 
(NZYTech) on the TGradient Thermocycler (Biometra), was performed to assess which 
colonies expressed the vector with the insert (positive colonies), by running the resulting 
products in another electrophorese gel. Subsequently, these colonies were selected for the 
growth of minicultures in LB medium (LB Broth powder, NZYTech) supplemented with 0.1% 
ampicillin (NZYTech), and minipreps were prepared using the NZYMiniprep kit (NZYTech). 
Each miniprep was sequenced to check if any mutations occurred during the procedure. 
From the miniculture, 400 µL were collected to a 2 mL tube and 100 µL of glycerol (≥99%, 
Sigma-Aldrich) were added to create a glycerol stock. 
Afterwards, midicultures were grown and midipreps were prepared using the 
NZYMidiprep kit (NZYTech). The DNA was quantified using Gen5™ software and 
equipment Synergy HT Multi-Mode Plate Reader (BioTek), and the samples were stored at 
-20 °C for posterior use in the transactivation assays. 
The Homo sapiens RXRα and PPARγ were kindly provided by laboratory colleagues 
(groups EDEC and AGE) who already used them in their experiments. The procedures used 
in the acquisition of these genes were analogous to the above mentioned.  
2.3.2. Fractionation of WWTP samples 
Water samples from the influent and post-UV treatment were collected from Sobreiras 
WWTP located in a residential area near the Douro’s river estuary in Porto, Portugal, on the 
26th of April 2016. 500mL samples, each with 5 replicates, were collected during a week 
and stored at -20 °C until use. Three of these replicates where sent for chemical analysis 
at the University of Santiago de Compostela. The remaining two were fractionated for use 
in transactivation assays. 
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For the fractionation, the collected samples were previously filtered and the pH values 
were measured. Oasis WCX and WAX (Waters) solid-phase extraction cartridges were 
conditioned with 5mL of methanol/formic acid (98:2) and ammonia solution 7N in methanol, 
respectively, followed by 5mL of methanol and 5mL of MiliQ water. The cartridges were 
then connected in series, where WAX was put on top. 100mL of each sample were 
percolated through the connected cartridges, followed by a washing step with 10 mL of 
MiliQ water. 
After a 30 min drying under vacuum, four fractions were collected with the following 
elution conditions designed to guarantee the maximum yield possible of putative nuclear 
receptor ligands: fraction A – 10mL of methanol (100%, VWR International); fraction B – 
10mL of ammonia solution 7N in methanol (Sigma-Aldrich); fraction C – 10mL of 
methanol/formic acid (98%, Merck) 98:2; fraction D – 10mL of ethyl acetate (99.7%, Sigma-
Aldrich). The obtained fractions were then blown to dryness under a nitrogen steam and re-
dissolved in DMSO, prior to use in transactivation assays, reaching a concentration of 200x 
the pure WWTP sample. 
2.3.3. Transactivation assay 
To characterize the RXRα, PPARγ and the heterodimer RXRα:PPARγ response to 
different compounds, the plasmids expressing the NR LBD fused with the yeast GAL4 DNA 
Binding Domain (DBD) were transfected into COS-1 cells (kidney, Chlorocebus sabaeus). 
This procedure consists on the binding of the GAL4 DBD to the promoter of the luciferase 
gene and the determination of the quantity of the enzyme produced. If the LBD of the NR 
under test is transactivated, the transcription of luciferase is increased and its concentration 
can be determined from its luminescence when a substrate of the enzyme is added. 
On the first day, viable COS-1 cells were counted in the Countess TM Automated Cell 
Counter (Invitrogen) using Trypan Blue Stain (0.4 %; Invitrogen), and distributed in a 24 
wells-plate, at a density of approximately 2×105 cells.mL-1, where they were grown in DMEM 
with phenol red (PANBiotech) supplemented with 1% Penicillin/Streptomycin (PANBiotech) 
and 10% fetal bovine serum (PANBiotech), for 24h at 37 °C and 5% CO2. 
The confluence of the cells (considered optimal around 80%) was checked on the 
following day under a microscope and the transfection was performed. For this procedure, 
a mix with Lipofectamine (Invitrogen) and Opti-MEM 1x (Gibco) was prepared (2μL 
lipofectamine + 23μL of Opti-MEM per well), as well as a mix with the testing plasmids, 
ensuring that each well has 500 ng of pBIND, 500 ng of pGAL4 and 750 ng of pcDNA3 (or 
pACT on the heterodimer assays). The two solutions were incubated separately for 5 min 
and then mixed and incubated at room temperature for another 20 min. The following step 
Obesity and environmental pollutants: a reason for concern? | 27 
 
consisted in preparing the transfection solutions by diluting each solution mix in Opti-MEM 
to perform a total volume of 350 μL/well. For this purpose, the DMEM was firstly removed 
from the plate, then the cells were washed with a DPBS solution (PANBiotech) and finally, 
the 350 μL of the transfection solution were added to each well and the cells were incubated 
for 5h at 37 °C and 5% CO2. 
Following the 5h of incubation, Danio rerio and Homo sapiens RXRα, PPARγ and the 
heterodimer RXRα/PPARγ were exposed to different treatments: DMEM without phenol-
red supplemented with 1% Streptomycin/Penicillin and 10% charcoal-treated Fetal Bovine 
Serum (PANBiotech) was contaminated with DMSO 0.1% (solvent control; 99.9%, Sigma-
Aldrich), TBT 250 nM (positive control; TBT chloride 96%, Sigma-Aldrich) and several 
WWTP samples (3 dilutions of pure WWTP sample, 1.25%, 2.5% and 10%, and the 4 
fractions of influent WWTP sample, fractions A, B, C and D, at a concentration of 1 µL of 
concentrated solution to 999 µL of DMEM without phenol-red). The transfection medium 
was removed from each well, the cells were washed with DPBS solution and were exposed 
to the different concentrations, followed by a new incubation for 24h at 37°C and 5% CO2. 
On the following day, cells were lysated with the Passive Lysis Buffer 5× (Promega) 
diluted in distillated water to a concentration of 1x and incubated at 37°C for 15 min at 90 
rpm. For the luciferase activity detection, the Dual-Luciferase® Reporter Assay System 
(Promega) was used. The luminescence was measured with the equipment Synergy HT 
Multi-Mode Plate Reader (BioTek), using the Gen5™ software. 
At least three replicates were performed for each transactivation assay in order to 
guarantee a correct statistical treatment of the data. 
2.4. Statistical analysis of data  
The statistical analysis was performed on IBM SPSS Statistics 24 software, where the 
normality and homogeneity of variance of all data was confirmed using Shapiro-Wilk and 
Levene’s tests, respectively, prior to analysis through one-way ANOVA. 
Subsequently, the Nile-Red fluorescence data and real-time PCR results were further 
analyzed through Fisher's Least Significant Difference (LSD) post hoc test, while 
transactivation data were examined by Bonferroni post hoc test. p-values lower or equal to 
0.05 were considered statistically significant. 
When parametric assumptions were not attained, the PCR and transactivation data 
were log-transformed and Nile-Red data was square-rooted. 
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All values were expressed as the average fold changes ± standard error of the mean 
(SEM) of the solvent control group. 
3. Results 
3.1. In vivo assay 
The results from the in vivo assay displaying lipid accumulation, analyzed through the 
fluorescent dye Nile-red, are presented in Figure 4. 
The values obtained from the Image J software correspond to the Integrated Density 
(the product of area and mean gray value) which represents the fluorescence captured for 
each larvae. Hence, the higher the values of Integrated Density, the higher the accumulation 
of lipids in larva. 
 
Figure 4. In vivo induction of lipid accumulation after exposure to TBT and WWTP influents. 
Values were expressed as the average fold changes ± SEM of the solvent control group. *p 
< 0.05 compared to solvent control (one-way ANOVA, followed by Fisher LSD’s test). 
The graph shows a clear increase in lipid accumulation of larva exposed to 100 ng/L Sn 
TBT, 200 ng/L Sn TBT and WWTP influent 2.5%. 
Interestingly, the lowest concentration of WWTP influent tested, 1.25%, did not show 
any augmentation of lipid accumulation, in opposition to the observed results at the highest 
concentration. 
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3.2. Real-time qPCR 
Figure 5 displays the effects of TBT and WWTP influents on the expression of key 
transcription factors and metabolizing enzymes, involved in adipogenesis and lipogenesis, 
in the bodies of zebrafish larvae: RXRα, PPARγ, SREBP1, ACOX1 and FASn. 
 
Figure 5. In vivo induction of lipogenic and adipogenic genes in zebrafish, following 
exposure to TBT and WWTP influents. Values initially normalized to β-actin and relative to 
an internal calibrator are expressed in the graph as the average fold changes ± SEM of the 
solvent control group. *p < 0.05 compared to solvent control (one-way ANOVA, followed by 
Fisher LSD’s test). 
Chronic exposure of zebrafish to the environmentally relevant concentrations of TBT 
(100 ng/L Sn and 200 ng/L Sn) did not affect the expression of transcription factors RXRα, 
PPARγ and SREBP1. 
In contrast, the expression of key lipogenic gene fatty acid synthase (FAS) was 
significantly up-regulated at the lowest TBT concentration, of 100 ng/L Sn. 
In regard to the WWTP influent treatments, all adipogenic and lipogenic genes were 
significantly changed after exposure, with up-regulations detected for RXRα, SREBP1 and 
FASn at all concentrations, and a statistically significant down-regulation of PPARγ at the 
lowest concentration tested (influent at 1.25%). 
The expression of acyl-CoA oxidase (ACOX), the enzyme involved in peroxisomal β-
oxidation, was not affected by any of the treatments. 
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3.3. Transactivation assays 
For the evaluation of a ligand/mixture’s ability to transactivate the nuclear receptors in 
vitro, the Dual-Luciferase® Reporter Assay System (Promega) was used. This method 
allows the measurement of the activity of 2 different luciferases, firefly luciferase (Photinus 
pyralis) and Renilla luciferase (Renilla reniformis), the latter being required as an internal 
control for the normalization of the data, since differences in amounts of cells between wells 
would lead to different levels of luminescence. Finally, the results were expressed as 
average fold changes of the solvent control. 
Graphical representations of the results of the transactivation of RXRα, PPARγ and the 
heterodimer are presented in Figure 6, Figure 7 and Figure 8, respectively.  
 
Figure 6. In vitro transactivation of Homo sapiens and Danio rerio RXRα by TBT and WWTP 
influents. The activity of firefly luciferase (Photinus pyralis) was normalized to the activity of 
Renilla luciferase (Renilla reniformis) and then expressed as average fold changes ± SEM 
of the solvent control group. *p < 0.05 compared to solvent control (one-way ANOVA, 
followed by Bonferroni test). 
The results from the assays with RXRα indicate that only our positive control (TBT at a 
concentration of 250 nM) was able to transactivate this receptor in both the Homo sapiens 
and the zebrafish.  
In regard to the WWTP influents, neither the fractions nor the pure influent caused an 
effect on the nuclear receptor. Although for the human RXRα, a slight dose-dependent 
increase seems to exist, these results were not considered statistically significant through 
one-way ANOVA. 
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Figure 7. In vitro transactivation of Homo sapiens and Danio rerio PPARγ by TBT and 
WWTP influents. The activity of firefly luciferase (Photinus pyralis) was normalized to the 
activity of Renilla luciferase (Renilla reniformis) and then expressed as average fold 
changes ± SEM of the solvent control group. *p < 0.05 compared to solvent control (one-
way ANOVA, followed by Bonferroni test). 
Surprisingly, TBT at 250 nM did not significantly enhance the transcription of the firefly 
luciferase gene by the PPARγ, even though there appears to be a slight induction of the 
Homo sapiens receptor. 
Likewise, both the fractions and the pure WWTP influent did not transactivate this 
receptor in either species. The concentration of 10% of pure influent appears to lead to an 
induction of the Danio rerio PPARγ activity, yet not considered statistically significant. 
Taking the results from both transactivation of RXRα and PPARγ together, it is possible 
to conclude that TBT is a far more powerful agonist of the RXRα in both species, in 
comparison to PPARγ. 
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Figure 8. In vitro transactivation of Homo sapiens and Danio rerio PPARγ:RXRα 
heterodimer by TBT and WWTP influents. The activity of firefly luciferase (Photinus pyralis) 
was normalized to the activity of Renilla luciferase (Renilla reniformis) and then expressed 
as average fold changes ± SEM of the solvent control group. *p < 0.05 compared to solvent 
control (one-way ANOVA, followed by Bonferroni test). 
The heterodimer transactivation results show that TBT does influence the activity of both 
Homo sapiens and Danio rerio PPARγ:RXRα heterodimers. However, the zebrafish 
heterodimer follows an inverse tendency when compared to the human heterodimer, as 
there is a massive repression at the tested concentration. Moreover, the response of this 
heterodimer contrasts with the response of the individual nuclear receptors, since a 
significant transactivation was detected for the RXRα exposed to TBT. 
The WWTP influent fractions did not transactivate the heterodimers, yet the pure influent 
appears to lead to a dose-dependent increase in transactivation, yet only statistically 
significant at a concentration of 10% for the Homo sapiens heterodimer. 
4. Discussion 
It has become clear that obesity is not simply the result of overeating and sedentary 
lifestyles, but instead, the product of a variety of internal and external factors, from which 
chemical exposure might play an important role. 
The study of lipid accumulation and adipogenesis from lower organisms to mammals 
has helped increase our knowledge of the molecular mechanisms behind lipid homeostasis 
and adipocyte formation. Regardless, many questions remain to be answered. 
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Even though many important features in the regulation of lipid homeostasis are 
conserved throughout metazoans, the large majority of studies have focused on the effects 
of obesogens in mammalian models (Capitão et al., 2017). Thus, for a better understanding 
of the effects and possible mechanisms of action of these obesogens across vertebrates 
as well, we have combined molecular and biochemical techniques, alongside with an in vivo 
assay with the vertebrate model species Danio rerio. Particularly, we addressed two key 
questions: What is the molecular mode of action of suspected obesogens? Are complex 
environmental samples able to induce an obesogenic response in the zebrafish? 
Our study demonstrates that exposure to environmental mixtures and a model 
obesogen, TBT, at environmentally relevant concentrations, induces mechanisms that favor 
adipogenesis and lipogenesis both in vivo and in vitro. 
Exposure of Danio rerio from hatching to the 18th day postfertilization to TBT at 100 ng/L 
Sn and 200 ng/L and to WWTP influent at a concentration of 2.5%, resulted in a significant 
accumulation of lipids, analyzed through Nile red staining. The Nile red is a fluorescent dye 
that acts as a hydrophobic probe and makes lipids fluoresce in tones of yellow to red 
depending on the degree of their hydrophobicity (Fowler & Greenspan, 1985), allowing the 
visualization and quantification of the fluorescence that is indicative of the lipid accumulation 
in the different treatments. 
Lipid staining techniques have been used several times to determine changes in lipid 
content following exposure to obesogens. Tingaud-Sequeira et al., (2011) presented the 
Zebrafish Obesogenic Test (ZOT) as an intermediate step in obesity research between in 
vitro and rodent assays. Their short-term assay method consisted in a 3-day treatment 
protocol with adiposity recordings prior and posterior to chemical exposure. The zebrafish 
larvae were reared on a standard diet until the first day of the protocol where two separate 
groups were fed for a day with different types of diet (standard diet or hard-boiled chicken 
egg yolk as a high-fat diet), followed by two days of starvation. After the first day of 
starvation, the initial adiposity was recorded and larvae were posteriorly exposed for 24 h 
to 50 nM TBT and 1 nM rosiglitazone, followed by a final adiposity recording. Similarly to 
our study, lipid droplets were analyzed through Nile red staining and a quantitative analysis 
the fluorescence was performed. The results indicated that the use of high-fat diets leads 
to a more dramatic increase in lipid adiposity when the fishes were exposed, as noted in 
the treatment with rosiglitazone which demonstrated the additive effect of the diet and 
chemical exposure. Additionally, TBT exposure led to adipocyte hypertrophy irrespective of 
the type of background diet while the larvae were in a fasting state (negative energy 
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balance), confirming that it has a strong obesogenic effect, even at environmentally-relevant 
concentrations. 
Zebrafish larvae exposed daily, from 3 dpf to 11 dpf, to tetrabromobisphenol A (TBBPA) 
and tetrachlorobisphenol A (TCBPA) both at 10 and 100 nM, TBBPA-sulfate (TBBPA-S) at 
125 and 250 nM or TBT at 0.1 and 1 nM, and fed with an egg yolk diet from the 6th to 10th 
dpf, exhibited a significant increase in lipid accumulation assessed by Oil Red O staining. 
The authors also pointed out that when the larvae were fed with a regular diet, instead of 
one with high-fat content, none of the treatments resulted in the staining of larvae, thus 
highlighting the impact of the synergy of both high-caloric diets and chemical exposure in 
obesity. Moreover, larvae exposed to relatively low concentrations of 100 nM TBBPA, 100 
nM TCBPA or 1 nM TBT from 3 to 11 dpf, fed with egg yolk diet, and then put in a chemical-
free housing system and fed with regular diet until 30 dpf, had a significantly higher body 
mass index, which demonstrates that exposure to halogenated BPAs during early 
development can lead to late-onset weight gain (Riu et al., 2014). 
3T3L1 preadipocytes treated with a mix of insulin with obesogens rosiglitazone (100 nM 
to 1 µM) or MEHP (monoethyl-hexyl-phthalate; from 10 µM to 100µM) for 10 days exhibited, 
in a dose-dependent manner, an induced adipogenic differentiation and increased 
triglyceride accumulation, analyzed through Oil Red O staining, whereas the parent 
compound DEHP (diethyl-hexyl-phthalate) did not influence adipogenesis (Feige et al., 
2007). 
Watt and Schlezinger (2015) treated bone marrow mesenchymal stem cells of 9-week-
old male C57BL/6J mice with rosiglitazone (100 nM), TBT (100 nM), triphenyltin (TPhT; 10, 
50 and 80 nm), MEHP, mono-(2-ethylhexyl) tetrabromophthalate (METBP), or TBBPA (10 
and 20 nM) and reported increases in lipid accumulation for all the toxicants tested, 
assessed through Nile Red staining (Watt & Schlezinger, 2015). 
In the zebrafish, lipids are mostly stored in the form of triacylglycerols in visceral, 
intramuscular and subcutaneous white adipose tissue (WAT) depots, with the first 
appearance being associated with the pancreas following exogenous nutrition from 8 to 12 
dpf or at a minimal size of around 5 mm (Hölttä-Vuori et al., 2010; Riu et al., 2014). 
The increase in white adipose tissue around visceral organs, as we found in our assay, 
is precisely the one related to obesity (Chamorro-Garcia & Blumberg, 2014; Moseti et al., 
2016). Indeed, different fat mass distribution exerts distinct effects on metabolic physiology, 
as abdominal adiposity is highly correlated with metabolic syndrome disorders and 
increased mortality (Chamorro-Garcia & Blumberg, 2014; Grün & Blumberg, 2009). 
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For a standard length of zebrafish larvae between 7.5 and 9 mm, the main anatomic 
locations for WAT were situated from the anterior dorsal limits of the visceral cavity to the 
rectum, above and around the two swim bladder chambers, close to the first loop of the 
anterior intestine, the posterior intestine and the rectum (Tingaud-Sequeira et al., 2011). In 
our study (total length of 6.55 ± 0.56 mm), we observed lipid accumulations in the same 
locations and we also noted that the appearance of WAT was mostly correlated to the size 
of the larvae rather than the age (data not shown) (Riu et al., 2014; Tingaud-Sequeira et 
al., 2011). 
Since fat build-up is controlled by the balance between lipogenesis and lipolysis 
(Kersten, 2001), we have included in our study the assessment of the impact that exposure 
to contaminants can have on both lipogenesis and adipogenesis (PPARγ:RXRα 
heterodimer, SREBP1, FASn) and also on fatty acid oxidation (ACOX1). Bodies of zebrafish 
larvae obtained at the end of the in vivo assay were analyzed by quantitative real-time PCR 
to determine whether the lipid accumulation verified in vivo was accompanied by changes 
in the levels of mRNA of key transcription factors and enzymes ruling lipid homeostasis. 
The results have demonstrated a differential expression in all genes following exposure to 
at least one of the treatments, with the exception of ACOX1, the enzyme responsible for 
fatty acid catabolism through β-oxidation in peroxisomes (Lyssimachou et al., 2015).  
Fatty acid synthesis begins with the conversion of acetyl-CoA to malonyl-CoA, a process 
catalyzed by acetyl CoA carboxylase (ACC), followed by the synthesis of a palmitate, by 
the FAS enzyme from malonyl-CoA, acetyl-CoA and NADPH, which is subsequently 
esterified into a triglyceride (Capitão et al., 2017; Guan et al., 2016). 
Surprisingly, even though the accumulation of lipids was evident for TBT treatments at 
both concentrations, no relevant changes in gene expression were detected at a molecular 
level. Only the mRNA for lipogenic enzyme FASn was increased compared to the controls, 
at the TBT concentration of 100 ng/L Sn (lowest concentration tested). These observations 
could be explained if a mechanism of negative feedback was occurring, set to restore the 
levels of lipids and mRNAs back to initial state. Regardless, as FASn is the enzyme 
responsible for de novo lipogenesis, the increase in its expression alone could indicate that 
lipids were still being produced in both TBT 100 ng/L Sn and WWTP treatments. Hence we 
hypothesize that these changes at a molecular level are indicative of posterior changes at 
a physiological level and that it could be the reason why in WWTP treatments the alterations 
in gene expression are more evident than in other treatments, while the lipid accumulation 
is less visible. It seems possible that if the time of exposure had been extended, the 
treatment with 1.25% of influent could have resulted in a significant increase in lipid 
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accumulation, as the impact of the influent at a molecular level in the larvae exposed to that 
concentration was already verified. Regarding the TBT treatments, we hypothesize that a 
mechanism of negative feedback could be in place, therefore diminishing the expression of 
the transcription factors and enzymes that would increase the lipid content. 
Another interesting detail in FASn expression is that in both treatments (TBT and WWTP 
influent), the highest concentrations appear to lead to a decrease in its mRNA levels when 
compared to the lowest concentrations, suggesting an inverted U-shaped dose-response 
curve, even though the differences between both doses were not considered statistically 
significant. This type of nonlinear dose-response relationship is apparently common in 
endocrine studies, where the highest concentrations lead to down-regulation, suppression 
or even compensation of the initial responses, in a phenomenon called “hormesis” 
(Lyssimachou et al., 2015). Regardless, for now we cannot affirm the existence of a dose-
response curve, based on so few concentrations tested. 
Other studies have reported increases in lipid accumulation that were not accompanied 
by changes in gene expression. Watt and Schlezinger (2015) reported that after treating 
bone marrow mesenchymal stem cells of male of 9-week-old C57BL/6J mice with 
rosiglitazone (100 nM), TBT (100 nM), TPhT (10, 50 and 80 nm), MEHP, METBP or TBBPA 
(10 and 20 nM), they observed lipid accumulation for all toxicants, yet TBT, TPhT and 
rosiglitazone had no statistical increases in PPARγ levels of mRNA, even though the 
downstream target genes had their expression up-regulated. In contrast, MEHP, TBBPA 
and METBP led to lipid accumulation and increase in levels of PPARγ and target genes, 
with METBP having, overall, the least potent action among these three chemicals (Watt & 
Schlezinger, 2015). 
Lipid metabolism in vertebrates is regulated through three different ways: allosteric 
regulation which comprises the control of enzyme activities through the binding of an 
activator or an inhibitor, post-translational modifications (e.g. phosphorylation) that can 
activate or deactivate the enzymes and transcriptional regulation controlled by transcription 
factors (Capitão et al., 2017; Wang et al., 2015). Nuclear receptor’s transcription is 
regulated by phosphorylation and dephosphorylation events mediated by specific kinases 
(Lyssimachou et al., 2015). 
The most well-known transcription factors regulating adipogenesis and lipogenesis, 
which have a broad overlap in their transcriptional targets, include the SREBPs, the 
CCAAT/enhancer binding proteins (C/EBPs) and the nuclear receptors that form 
heterodimers with RXR [PPARs, pregnane X receptor (PXR), liver X receptor (LXR) and 
farnesoid X receptor (FXR)] (Capitão et al., 2017; Grün & Blumberg, 2007; Lyssimachou et 
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al., 2015; Moseti et al., 2016). Many other factors, such as insulin, glucocorticoids and 
Insulin-like growth factors (IGFs), influence adipogenesis directly or indirectly by stimulating 
the expression of some of the previously mentioned genes (Lyssimachou et al., 2015). 
C/EBPβ, SREBP1 and insulin stimulate the expression of PPARγ. SREBP-1, stimulated by 
insulin secretion, is involved in both cholesterol and fatty acid synthesis and regulates the 
expression of de novo lipogenesis enzymes FASn and ACCα (Capitão et al., 2017; Kersten, 
2001; Lyssimachou et al., 2015). The RXRα:PPARγ heterodimer, alongside C/EBPα, 
regulates the expression of adipogenic and lipogenic genes. C/EBP-family members also 
regulate the expression of 11beta-hydroxysteroid dehydrogenase (11β-HSD) 1 and 2, 
responsible for glucocorticoid homeostasis, and IGF-I and II, which play roles in growth, cell 
proliferation and development (Kersten et al., 2001; Lyssimachou et al., 2015). 
Alongside SREBP1, LXR is a key regulator of cholesterol metabolism, although its 
effects are opposite to the former, as it decreases the cellular cholesterol levels (Hölttä-
Vuori et al., 2010). The SREBP family are membrane-bound transcription factors which 
directly regulate the expression of more than 30 genes involved in synthesis and uptake of 
cholesterol, fatty acids, triglycerides and phospholipids (Horton et al., 2002). Just like 
PPARγ, SREBPs are also subjected to PTMs, such as phosphorylation, acetylation, 
ubiquitination and sumoylation, which can affect the processing, transcriptional activity and 
stability or degradation of the proteins (Wang et al., 2013). 
In our study, the expression of transcription factors RXRα, PPARγ and SREBP-1 was 
influenced by the environmental mixtures. Curiously, while RXRα and SREBP-1 were 
significantly overexpressed at both concentrations of WWTP influent, the PPARγ levels 
were clearly repressed at the lowest concentration of 1.25% and were not significantly 
affected at the concentration of 2.5%. 
Many studies report the deregulation of lipid homeostasis in vivo, following TBT 
exposure, associated with transcriptional alteration of lipogenic and adipogenic genes. 
Lyssimachou et al. (2015), exposed Danio rerio, from pre-hatch to 9 months, to lower 
environmental concentrations of TBT (10 and 50 ng/L Sn) than the ones used in our study 
and reported changes in body weight, condition factor, hepatosomatic index, hepatic 
triglycerides and also changes in the expression of key transcription factors and enzymes 
involved in adipogenesis and lipogenesis [RXRα/a, PPARγ, SREBP1, FASn, ACOX1, 
C/EBPα, C/EBPβ, carbohydrate-responsive element-binding protein (ChREBP), acetyl- 
CoA carboxylase alpha (ACCα), diacylglycerol O-acyltransferase 2 (DGAT2)], 
glucocorticoid metabolism (11β-HSD2 and 11β-HSD3α) and growth and development (IGF-
I and IGF-IIα) in the brain and liver of the fish. They have also identified the brain as a novel 
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target for TBT action and observed a sexual dimorphism in both morphological parameters 
(e.g. body weight, condition factor, liver triglyceride content and hepatosomatic index) and 
transcription of genes in the liver, as well as a tissue-specific impact of TBT in the 
metabolism. 
In comparison to our study, Lyssimachou et al. reported an up-regulation of the 
expression of PPARγ in the liver in both genders (while the brain levels remained 
unchanged), with a concomitant increase in hepatic triglyceride levels, upregulation of 
SREBP1 and its encoding enzyme FASn in males. The transcription of RXRα in the liver 
was down-regulated in males at 50 ng/L Sn and upregulated in females at 10 ng/L, while in 
the brain a down-regulation was observed for both genders at the lowest concentration 
tested. In the brain of males, FASn was downregulated at 10 ng/L, while SREBP1 was 
significantly upregulated at 50 ng/L along with the FASn levels, although not statistically 
significant. In the brain of females, ACOX1 levels were significantly decreased. Similarly to 
our study, statistically altered gene expression was not always paired with lipid 
accumulation. The female fish at the lowest TBT concentration (10 ng/L) demonstrated an 
upregulation of the expression of RXRα and PPARγ, among other lipogenic/adipogenic 
genes, which was not coupled with an increase in hepatic lipid accumulation, and male fish 
exposed to 50 ng/L showed an upregulation of de novo lipogenesis genes SREBP1 and 
FASn, although no significant increases in triglyceride levels were observed. 
Moreover, 11β-HSD2, the enzyme that deactivates cortisol was down-regulated in the 
liver and up-regulated in the brain, while 11β-HSD3α, the cortisol synthesizing enzyme, was 
down-regulated in the brain, which is consistent with previous reports indicating that TBT 
might interfere in glucocorticoid homeostasis (Grün & Blumberg, 2009). 
Likewise, the effects of TBT on lipid homeostasis in other teleosts species 
(Oncorhynchus tshawytscha, Carassius auratus and Sebatiscus marmoratus), with 
observed effects such as increases in lipid content, number and size of adipocytes 
(adiposity), altered body weight and expression of genes in the downstream pathways of 
nuclear receptors such as PPARγ and RXR were reported (Capitão et al., 2017). 
PPARγ also plays an important role in lipogenesis in organs where it is minimally 
expressed, as it is the case of the liver, where the increase in expression is linked to hepatic 
triglyceride accumulation (Kersten, 2001). Nonetheless, in hepatocytes, the main mediator 
of the expression of lipogenic genes is SREBP-1, in contrast to the adipose tissue, where 
PPARγ has the most important role (Kersten, 2001). Since these genes, among others, are 
mostly expressed in specific organs, the whole-body evaluation of their levels of mRNA, as 
we applied in our study, might not have been the best strategy to detect statistically 
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significant differences in their expression after chemical exposure. The small size of our 
larvae did not allow an organ-specific assessment of the mRNA levels, hence the obtained 
information might not accurately reflect the changes in gene expression that might have 
happened in certain organs, leading to a sub-estimation of the differences detected between 
the control and contaminated treatments, especially for TBT treatments.  
Other compounds have been shown to influence lipid homeostasis in vivo and in vitro, 
with changes in the expression of key genes. 
Perfluorononanoic acid (PFNA), a perfluoroalkyl acid with wide commercial and 
consumer applications that can be found in environmental matrices, has been shown to 
decrease body weight, body length and hepatosomatic index of both zebrafish sexes, after 
exposure of 5-month old zebrafish for 180 days at concentrations of 0.01 (environmentally 
relevant), 0.1, and 1.0 mg/L in water. In contrast, the liver cholesterol levels increased in 
both sexes, whereas the liver triglyceride content was increased in males and decreased in 
females, matching the observation that the PFNA accumulates more in male livers than in 
females’. Moreover, PPARs and C/EBPs gene expression was enhanced in males and 
depressed in females (Zhang et al., 2012). The authors suggested that the decrease in 
fatty-acid binding proteins (FABPs), PPARs, C/EBPs and triglyceride content in female 
livers could be due to a liver-ovary feedback loop, as female ovaries require a substantial 
amount of lipids during their development, thus promoting a liver-mediated diversion of the 
lipids towards the ovaries. 
Exposure of BALB/c mice for 14 days to PFNA also led to a decrease in body weight (at 
3 and 5 mg/Kg PFNA per day via gastric gavage), upregulation of the expression of PPARα 
and γ in the thymus (at 1 mg/kg PFNA per day) and increase in cortisol and 
adrenocorticotrophic hormone levels in sera, although no changes in the expression of the 
glucocorticoid receptor in the thymus were detected (Fang et al., 2008). 
The effects of MEHP (a metabolite of DEHP) and rosiglitazone on gene expression were 
investigated using a collection of 17 000 mouse cDNAs in gene expression array analyses 
and the results indicated that the majority of the genes were regulated by both chemicals, 
suggesting that the effects of MEHP are possibly mediated by PPARγ as well. Both 
catabolic and anabolic pathways were affected, with up-regulated genes belonging to the 
β-oxidation, citrate cycle, glucose uptake and glycolysis, oxidative phosphorylation and 
genes required for lipid droplets’ structure and function of mature adipocytes (lipogenesis, 
triglyceride synthesis and adipokines). However, rosiglitazone specifically regulated around 
30% of the total analyzed genes, showing a broader action than MEHP (Feige et al., 2007). 
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Chamorro-Garcia and colleagues tested the obesogenic effects of TBT and 
rosiglitazone on C57BL/6J mice at a transgenerational level. After developing an assay 
where the parental generation (F0) was exposed through drinking water to rosiglitazone 
(500 nM) and environmentally relevant concentrations of TBT (5.42, 54.2 and 542 nM), the 
F1 generation was exposed in utero, the F2 exposure could only result from exposed germ 
cells and F3 generation had no exposure at all, they have noted that TBT led to an increase 
in WAT, increase in hepatic lipid accumulation, alteration in the expression of genes related 
to lipid storage and transport, lipogenesis as well as lipolysis, and biased MSC programming 
towards the adipocyte lineage at the expense of osteogenic lineage in all generations. 
Among the analyzed target genes, the ones mentioned in our study, PPARγ, PPARα, 
SREBP-1, FASn and ACOX, were all up-regulated in both males and females of all three 
generations exposed to either TBT or rosiglitazone. Similarly to our study, the main WAT 
depots that suffered increases after TBT-exposure were located in the visceral area 
especially in F2 males, and to a lesser extent in F1 males. Other locations for increases in 
WAT included the perirenal and interscapular depots. The F3 males showed significant 
increases in the adipocyte sizes and number and in the weights of all WAT depots, 
confirming the presence of transgenerational effects. Within the animals exposed to 
rosiglitazone, the only statistically significant differences in WAT were observed for F1 
males, with increases in the epididymal depot weight and adipocyte size. Once again, sex-
specific effects were noted, with the females showing more modest changes in adipose 
tissue and genes expression profiles even after TBT exposure (Chamorro-Garcia et al., 
2013). 
In our study, a gender-specific evaluation of the effects was not possible to be obtained, 
as the zebrafish on the last day of the assay (18th-day postfertilization) had not yet attained 
sexual differentiation, which usually begins around the 25th day postfertilization (Santos et 
al., 2017). 
The effects of BPA and analogs have been observed in other teleost species. Juvenile 
sea bream fish (Sparus aurata) contaminated through the diet for 21 days with 
xenoestrogens BPA, nonylphenol and octylphenol (all with two doses: 5 mg/kg and 50 
mg/Kg of body weight), showed significant increases in hepatic lipid accumulation and 
steatosis and overexpression of nuclear receptors involved in lipid homeostasis PPARα, 
PPARβ and PPARγ at the highest doses, lower doses and all doses of all chemicals, 
respectively. RXR and FAS levels were also significantly increased by nonylphenol, 
respectively, at the highest dose and all doses. The lowest concentration of BPA also 
upregulated RXR and at the highest concentration, an increase in FAS mRNA levels was 
observed. Moreover, these contaminants also led to a reduction in food intake after 
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exposure to all chemicals, although an increase in plasma cortisol levels was detected in 
nonylphenol- and octylphenol-exposed fish (Maradonna et al., 2015). 
Similarly, five-month old rare minnow Gobiocypris rarus, exposed to waterborne BPA at 
concentrations of 15 µg/L for 28 days, exhibited a significant decrease in serum triglyceride 
content of females, a non-significant increase in hepatic and serum triglyceride content in 
males alongside an upregulation of lipid synthesis demonstrated by the increased activities 
of de novo lipogenesis enzymes ACC and FASn in both sexes and glycerol-3-phosphate 
acyltransferase (GPAT) in males, even though fatty acid β-oxidation was also enhanced 
[increased activity of carnitine palmitoyltransferase I (CPT1), considered the main 
regulatory enzyme of long-chain fatty acid oxidation, in the liver of males]. Clear gender-
specific effects were observed, as females displayed decreased GPAT and CPT1 activity, 
which was consistent with the decrease in triglyceride content (Guan et al., 2016). Another 
particularly interesting detail in this study is that the changes in gene expression were not 
always consistent with the respective enzyme activity (e.g. reduced mRNA levels of GPAT 
but increased activity of the enzyme in males), which could possibly occur due to a negative 
feedback regulation. Regardless, the common assumption that mRNA expression has a 
direct correspondence with protein expression (central dogma of molecular biology) or 
protein activity is not fully correct, as many factors influence the correlation between them, 
such as different half-lives and post-transcription machinery (Benninghoff, 2007; Haider & 
Pal, 2013). The advantage of studying proteins instead of transcripts lies on the fact that 
they are truly responsible for the phenotypes of cells, organs and organisms and for the 
cellular responses to physiological stimuli, while mRNA is only the first step of a long 
sequence of events culminating in protein synthesis (Benninghoff, 2007; Graves & 
Haystead, 2002). 
To further understand the molecular mode of action of the environmental samples and 
TBT, we have performed transactivation assays with the human and zebrafish PPARγ and 
RXRα receptors, as well as with the RXRα:PPARγ heterodimer. 
Nuclear receptors’ ligands are usually small hydrophobic molecules (Castro and Santos, 
2014; Zhao et al., 2015), yet very diverse and since PPARs are known to have a large 
ligand-binding pocket, it is no surprise that many different groups of chemicals have been 
shown to interact with these nuclear receptors (Capitão et al., 2017). 
Our results indicate that both the WWTP influent and the TBT are able to interact with 
the receptors in vitro, which might possibly be one of the mechanisms underlying the 
observed lipid accumulation in vivo. TBT at a concentration of 250 nM transactivated the 
Homo sapiens RXRα and heterodimer, but did not significantly transactivate PPARγ, even 
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though there appears to be an increase in activity in the Homo sapiens PPARγ. Surprisingly, 
the results for the Danio rerio receptors show a different tendency when compared to the 
human receptors. While the zebrafish RXRα activity was significantly induced and the 
PPARγ did not appear to be influenced by TBT, the heterodimer was massively repressed 
at the concentration tested. Our transactivation results for the zebrafish PPARγ and 
heterodimer seem to be in accordance with the results obtained for the expression levels of 
PPAR in our in vivo assay. Indeed, although an increase in PPARγ expression would be 
expected to lead to an increase in lipogenesis, what we have observed is that the 
statistically significant accumulation of fat in both TBT and influent treatments was either 
accompanied by no changes in PPARγ expression (TBT treatments and 2.5% influent) or 
even a decrease in its expression (at 1.25% influent). 
The mammalian nuclear receptors RXRα and PPARγ possess orthologues in fish, which 
are expressed since early development (Lyssimachou et al., 2015). The three PPAR 
isoforms (α, β and γ), which are critical lipid sensors and regulators of lipid metabolism, are 
conserved in the zebrafish and have similar distribution and roles as they have in mammals 
(Hölttä-Vuori et al., 2010), even though teleosts possess five PPARs (Capitão et al., 2017; 
Santos et al., 2012). Five of the RXR sequences found in the zebrafish were analyzed and 
both their DNA-binding domain (DBD) and ligand-binding domain (LBD) have high 
sequence similarities (from 88 to 99%) to those of humans, supporting the idea of similar 
ligand affinities (Ouadah-Boussouf & Babin, 2016). More specifically, both DBD and LBD of 
RXRα from Danio rerio have a % of similarity with the human amino acid sequences of 99%, 
while the PPARγ amino acid sequences are similar in only 94% at the DBD and 74% at the 
LBD (Zhao et al., 2015). Hence, the zebrafish PPARγ binding specificity is possibly different 
from the human’s. 
The position 285 of Danio rerio PPARγ contains a tyrosine, oppositely to the Homo 
sapiens PPARγ which holds a cysteine in the homologous position (Capitão et al., 2017). It 
is possible that the mutation existent in the zebrafish PPARγ is the reason behind the 
disparity between the transactivation results, as differences in the nuclear receptor’s 
structures may lead to distinct chemical binding and activation outcomes, besides the fact 
that the cysteine in the human PPARγ was proven to be essential for the activation of this 
receptor by TBT, as this chemical did not bind to the receptor when the residue Cys285 of 
the LBD was mutated into a residue of alanine (Capitão et al., 2017; Harada et al., 2015). 
Indeed, the disadvantage of using zebrafish is that, due to the whole-genome duplication 
that occurred in teleost evolution, the species acquired two more pairs of chromosomes 
compared to the human being and thus, changes in the expression of these paralog genes 
are not easily extrapolated to other vertebrates (Hölttä-Vuori et al., 2010; Hill et al., 2005). 
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Surprisingly though, this mutation in zebrafish PPARγ is not present in other Actinopterygii 
members Sparus aurata and Pleuronectes platessa, which maintain the cysteine molecule 
in the correspondent position (Capitão et al., 2017). 
Although TBT is known for being an agonist of the PPARγ, and despite the label of this 
receptor as the “Master regulator of adipogenesis”, it has been suggested that TBT might 
activate the heterodimer through RXR, since this chemical was also reported to interact with 
other permissive heterodimers (LXR:RXR heterodimer) (Capitão et al., 2017; Le Maire et 
al., 2009). Similarly, Le Maire et al., (2009) confirmed the transactivation of RXR:PPARγ by 
TBT and reported the covalent binding of TBT to the Cys432 of human RXRα as a crucial 
event for the activation of this receptor. They have also suggested that the interaction of 
TBT with the Cys285 of PPARγ does not allow an efficient stabilization of the active receptor 
conformation, besides the fact that organotins have been shown to bind to the receptor via 
a non-covalent ionic bond between the tin atom and the cysteine (Harada et al., 2015), thus 
explaining why the TBT-dependent modulation of the activity of the heterodimer is most 
likely to occur through the binding to RXR instead. Indeed, our results also show that TBT 
is a far more powerful agonist of RXRα in both species, when comparing to PPARγ. 
Moreover, Ouadah-Boussouf and Babin (2016) demonstrated that the obesogenic effect 
of TBT on the zebrafish RXR:PPARγ was not inhibited by the human PPARγ antagonist 
T0070907, but was fully abolished by the human RXR antagonist UVI3003 and by a 
combination of human RXR:RXR and RXR:PPARγ antagonists, once again proving that 
RXR plays a central role in TBT-modulated obesogenic outcomes and that in vivo 
obesogenic effects might occur through RXR-dependent pathways which do not necessarily 
involve PPAR isoforms. 
Indeed, our study was not the only one showing a lack of transactivation of zebrafish 
PPARγ by TBT in vitro (Riu et al., 2014). 
Several other compounds have been shown to activate nuclear receptors involved in 
lipid homeostasis in vitro. 
Bisphenol A and TBBPA are manufactured chemicals that can originate a variety of 
analogs when reaching the environment. TBBPA is debrominated into monoBBPA, diBBPA 
and triBBPA. TCBPA, although also produced for its use as flame retardant like TBBPA, 
can also be formed spontaneously in the environment from chlorination of BPA. The 
halogenated BPA derivatives (TBBPA and TCBPA) have been shown to activate human 
ERα, ERβ, and PPARγ (Riu et al., 2011). 
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Despite being a model xenoestrogen, BPA was shown to have a much lower estrogenic 
activity (ability to bind to estrogen receptors α and β) than 17β-estradiol and chlorinated 
BPA analogs, while the brominated analogs are less estrogenic than BPA, with their 
potency decreasing as the number of bromine atoms increases. The transactivation of ERα 
and ERβ by these compounds followed the ranking order BPA > monoBBPA > diBBPA > 
triBBPA with TBBPA showing no estrogenic activity at all, whereas in the assays with 
PPARγ, the compounds were ranked in the inverse order (triBBPA = TBBPA > diBBPA > 
monoBBPA), with BPA showing no influence on PPARγ activity (Riu et al., 2011).  
TBBPA and TCBPA are agonists of human PPARγ, although their activity is about 100-
fold less potent than rosiglitazone. Furthermore, they have triggered a similar PPARγ 
activation at 10-to 100-fold lower concentrations (micromolar range) than known PPARγ 
ligands MEHP, perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA), and 
when in the presence of [3H]-rosiglitazone, these compounds competitively inhibited the 
binding of the later to the receptor. Rosiglitazone‘s larger size and higher number of 
hydrogen bonds formed with the ligand binding protein of the PPARγ, when compared to 
BPA and halogenated BPAs, could explain its higher affinity for the receptor. TBBPA, 
TCBPA, MEHP (all at 10 µM) and rosiglitazone (at 1µM) were tested for their ability to bind 
to human, zebrafish and Xenopus PPARγ receptors. Among these, TBBPA, TCBPA and 
MEHP all activated the human and zebrafish PPARγ, with MEHP being the weakest ligand 
of the zebrafish receptor while rosiglitazone did not activate the zebrafish receptor, and all 
compounds activated the Xenopus PPARγ. The authors also suggested that the 
replacement of human PPARγ Gly284 by serine residues and Cys285 by tyrosine residues 
in the zebrafish receptor could be the reason behind the observed reduced binding affinity 
of rosiglitazone, in the same way that the different binding mode of the halogenated BPAs 
would allow their binding to both human and zebrafish PPARγ (Riu et al., 2011).  
To further investigate the ability of these compounds to induce adipogenesis, Riu and 
collaborators analyzed the adipocyte differentiation (using NIH3T3L1 preadipocytes) after 
exposure through Oil Red O staining and verified that TCBPA and TBBPA at 10 μM induced 
adipogenesis, while co-treatment with PPARγ antagonist CD5477 inhibited the adipocyte 
differentiation by TBBPA, suggesting that this chemical mediates its effects on adipogenesis 
through PPARγ. Furthermore, TBBPA and TCBPA led to a similar expression of PPARγ 
gene and diminished expression of its target gene ApoA2/FABP4 (AP2) when compared to 
the treatment with rosiglitazone (Riu et al., 2011). 
The potential of halogenated-BPAs as human PPARγ ligands has also been verified in 
vivo, using a transgenic line of zebrafish embryos [Tg(hPPARγ-eGFP)] to investigate 
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whether the receptor was activated and where this activation occurred in the whole 
organism (Riu et al., 2014). A 24-hour exposure to rosiglitazone led to a strong green 
fluorescent protein (GFP) expression in the epidermis of the whole embryo, while exposure 
to 100 nM and 1 µM TBBPA and 1 µM TCBPA, led to the expression of GFP to a lesser 
extent, focused on the head and tail regions. TBBPA-S (1 µM), a sulfate-conjugated 
metabolite of TBBPA formed in the larvae, also activated the receptor in vivo. TBBPA, 
TCBPA and TBBPA-S exhibited a weak agonistic activity towards zfPPARγ in vitro, with 
TBBPA being the most potent, whereas TZDs (rosiglitazone, pioglitazone, ciglitazone and 
troziglitazone), a prostaglandin and TBT did not activate the receptor in vitro (Riu et al., 
2014). The authors have concluded that known human PPARγ ligands can therefore not be 
used as positive controls in assays involving the zebrafish PPARγ. Indeed, this conclusion 
matches the results obtained in our study, as the well-known obesogen TBT did not 
influence PPARγ transactivation in the zebrafish. 
Feige et al., (2007) showed that different PPARγ ligands (DEHP and rosiglitazone) lead 
to the recruitment of distinct coactivators and selectively regulate the interactions between 
coregulators, which not only has an impact on the size of the transcriptional complex, but 
can also influence the different activities and intensities of the physiological effects noted 
between ligands, since it might lead to a differential gene regulation.  
Feige and colleagues (2007) described that the obesogenic effects of MEHP on 3T3L1 
cells were lower than those induced by rosiglitazone, yet the effects of this chemical were 
also shown to require the PPARγ, as the treatment with the GW9662 antagonist and PPARγ 
knock-down significantly inhibited the adipogenic action of both MEHP and rosiglitazone 
treatments. MEHP was shown to have a similar binding mode to the PPARγ LBD when 
compared to rosiglitazone (same residues contacted: Ser289, His323, His367 and Tyr473), 
yet as MEHP promotes interactions with only a subset of PPARγ coregulators, the 
conformational changes provoked by these ligands on the receptor are different. 
Furthermore, MEHP activated mouse PPARα, β and γ and human PPARγ, but with a 
maximal activation at 100 µM of about half of the achieved with rosiglitazone. Regardless, 
the effects were noted at levels of 3.2 µM, which is very concerning, since plasmatic levels 
of DEHP and MEHP as high as 50 µM have been reported in humans (Feige et al., 2007). 
Takacs and Abbott (2007) evaluated the ability of PFOA and PFOS to activate mouse 
and human PPARα, β and γ, at concentrations within the ranges found in rats and mice 
maternal serum (0.5-250 µg/mL), using Cos-1 cells in transient transfection assay following 
a 24h period of exposure. PFOA’s transactivation potential was higher than PFOS in both 
species, with PPARα and β activities being enhanced, while PPARγ activation was not 
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significant for either of these chemicals. Moreover, the PPARα antagonist MK-886 
suppressed the effects of both chemicals in both species, whereas the PPARγ antagonist 
GW9662 only suppressed the activation of the human isoform for PFOA. Troglitazone, used 
as a positive control, increased activity of both human and mouse PPARγ (Takacs & Abbott, 
2007). 
Both studies of Takacs and Abbott (2007), as well as Feige et al., (2007), have pointed 
out the existence of a disparity in results as different cell types were used. Particularly, Feige 
et al. reported different efficacies of MEHP (relative to the reference agonist rosiglitazone) 
to transactivate PPARγ in different cell lines, reaching 80% of the reference activation level 
in C2C12 cells, 60% in COS-7 cells and only 35% in HeLa cells (Feige et al., 2007). These 
observations were even more accentuated when Takacs and Abbott compared their lack of 
PPARγ activity after PFOA exposure on COS-1 cells, to the results reported by Vanden 
Heuvel et al., where this chemical activated PPARγ in 3T3-L1 cells at the same 
concentration tested (100 µM) (Takacs & Abbott, 2007; Vanden Heuvel et al., 2006). Thus, 
the ability of certain compounds to activate nuclear receptors might be cell-type dependent. 
Fibrates are examples of pharmaceuticals, used to treat hypercholesterolemia in 
humans, which are ubiquitously present in aquatic ecosystems and lead mostly to a 
depletion of lipid levels (Capitão et al., 2017; Coimbra et al., 2015). A multigenerational 
study on zebrafish with a whole life-cycle exposure of an F0 generation to the clofibric acid, 
a metabolite of the pharmaceutical clofibrate designed to lower blood lipid content through 
its action of PPARα, at concentrations of 1 and 10 mg/g (diet), reported differential effects 
across generations. The F0 fishes had a significant reduction in weight and muscle 
triglyceride levels parallel with increases in liver mRNA levels of PPARα and ACOX1, 
oppositely to their offspring (F1 generation) which exhibited an increase in weight with a 
concomitant upregulation of PPARγ and down-regulation of PPARβ, involved in lipid 
mobilization, at the highest concentration tested (Coimbra et al., 2015). 
The activation of PPARα by fibrates is well described in the literature. Ciprofibrate has 
been used as a positive control for testing of human and mouse PPARα activation by new 
environmental chemicals (Vanden Heuvel et al., 2006) and as previously mentioned, 
fenofibrate is also a PPARα agonist, besides its interference in glucocorticoid homeostasis 
(Fang et al., 2008). 
In addition to the already mentioned alterations of PPARs gene expression, the 
alkylphenols nonylphenol and octylphenol have also been reported to activate the human 
estrogen receptor, a possible mode of action of many obesogens (Bonefeld-Jørgensen et 
al., 2007). Bonefeld-Jørgensen and colleagues reported that BPA, BPA dimethacrylate, 
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nonylphenol and octylphenol all exhibited estrogenicity (BPA and nonylphenol having the 
highest potency compared with 17β-estradiol), antagonized the androgen receptor 
transactivation (in a similar order of potency), inhibited the aromatase activity and interacted 
with the aryl hydrocarbon receptor (involved in steroid synthesis and metabolism) in vitro. 
Rosiglitazone, MEHP, METBP, TBBPA and the organotins TBT and TPhT were all 
shown to activate the mouse PPARγ1 and 2 in Cos-7 cells, with the TZD and the organotins 
having the highest potencies and efficacies, whereas the remaining chemicals only acted 
as partial agonists (Watt & Schlezinger, 2015). 
Regarding our transactivation results with the influents, only the concentration of 10% 
pure influent caused a statistically significant effect in the transactivation of the human 
heterodimer, even though there appears to be a dose-dependent increase in the activity of 
both human and zebrafish heterodimers. It is important to take into consideration that the 
concentrations of 1.25% and 2.5% tested correspond to the concentrations used in our in 
vivo assay, where zebrafish larvae were chronically exposed from the 4th to the 18th day 
postfertilization. Hence, the results are not easily comparable, since the transactivation 
assays include a short window of exposure of only 24 hours, which can explain the lack of 
transactivation at these low concentrations. 
In relation to the WWTP influent fractions, no statistical results were obtained for any of 
the assays. Even though the concentrations of the fractions tested correspond to 20% of 
the pure WWTP influent, the total compounds are being divided into the 4 fractions (A, B, 
C and D) corresponding to different elution conditions, hence the transactivation caused by 
the fractions individually could be far less powerful than the transactivation obtained from 
pure influent where all the compounds are combined, as the simultaneous exposure to this 
“cocktail” of obesogens can potentially lead to additive, or even synergistic effects (e.g. by 
acting on both RXR and PPARγ simultaneously) (Biemann et al., 2014; Riu et al., 2011). 
On the other hand, as several compounds have also been shown to repress the activity of 
the nuclear receptors, the possibility that antagonistic actions of different chemicals on the 
nuclear receptors might exist cannot be rejected (Biemann et al., 2014). 
In general, our study has shown that complex environmental mixtures are able to 
deregulate metabolic pathways, leading to an increase in lipid accumulation and 
adipogenesis. So far, not many studies have reported the impact of chemical mixtures on 
obesity and related-disorders, which is concerning, as real-life exposure occurs to mixtures 
rather than to single chemicals. The effects of exposure to the environment are even less 
known, thus, we have included WWTP influents in both transactivation assays and the in 
vivo assay with zebrafish. WWTP influents contain a variety of potential obesogens, 
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alongside with other chemicals with a possible anti-obesogenic activity (e.g. fibrates, 
phytoestrogens and other estrogenic compounds). All the previously cited obesogens and 
anti-obesogens are routinely detected in the environment and WWTPs, alongside with 
many other EDCs that can possibly interfere with lipid homeostasis (Betts, 2007; Clara et 
al., 2010; Huang et al., 2012; Loos et al., 2013; Martí et al., 2011; Riu et al., 2011). 
Moreover, WWTP samples are well-known for their estrogenicity (Loos et al., 2013) and 
compounds with estrogenic activities, such as BPA and DES, have been linked to the 
disruption of lipid homeostasis (e.g. through activation of ERs) in a diversity of animal 
groups (Capitão et al., 2017; Newbold et al., 2009). 
Possible mechanisms of obesogen action include the direct binding to nuclear receptors 
(such as the oestrogen receptor α and the PPARγ) by acting as either agonist or antagonist, 
and indirectly through the inhibition of enzymatic activity or activation of the expression of 
p450 enzymes (Bašić et al., 2012). To further complicate the picture, the same compound 
can have multiple modes of action, as it is the case of TBT, that is also known to affect 
glucocorticoid homeostasis and the expression of aromatase mRNA and its enzymatic 
activity, as well as phthalates, known to activate PPARα while their metabolites have a 
preference for PPARγ, favoring a lipolysis state (Grün & Blumberg, 2009). Halogenated 
BPA derivatives (TBBPA and TCBPA) are other examples of chemicals with many possible 
mechanisms of action in the disruption of lipid homeostasis, by disrupting thyroid hormone 
receptor, estrogen receptors and the PPARγ signaling (Bašić et al., 2012; Riu et al., 2011) 
Moreover, besides having multiple modes of action, obesogens may also elicit 
compensatory mechanisms (Bašić et al., 2012; Grün & Blumberg, 2009), which complicate 
the interpretation of results. Additionally, as lipogenesis and adipogenesis are commanded 
by a complex network of transcription factors and enzymes, all mechanisms could also 
interact with each other, leading to disruptions at many levels (Bašić et al., 2012). 
Being a permissive heterodimer, the RXRα:PPARγ can be activated by the binding of 
an agonist to either nuclear receptor (Grün and Blumberg, 2007). Hence, the outcomes of 
this chemical-mixture exposure could not be easily predicted. A future chemical 
characterization of our WWTP samples and fractions will allow a better understanding of 
what we are dealing with, as for now, we do not possess any information on the compounds 
and respective concentrations in the samples. Moreover, this step might eventually help us 
discover new potential obesogens. 
Several authors have also pointed out the need to investigate the effects of mixtures of 
chemical obesogens to which the human being is exposed and understand their mode of 
action (Benninghoff, 2007; Biemann et al., 2014; Chamorro-Garcia & Blumberg, 2014). 
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Moreover, many studies have mentioned the need to develop high-throughput large-scale 
screening techniques that could be used to evaluate the toxicity of many chemicals at once, 
in addition to single-chemical investigations (Benninghoff, 2007; Hill, 2005).  
 In that matter, Biemann et al. (2014) exposed multipotent murine mesenchymal stem 
cells (C3H10T1/2) to a mixture of BPA, DEHP and TBT, and concluded that the impact of 
this mixture on adipogenesis was not predictable from the effects of each compound 
individually. Whereas single BPA exposure decreased the number of adipocytes, 
triglyceride content and expression of adipogenic genes, and single DEHP and TBT 
massively induced the opposite effects, the mixture promoted adipogenesis although with 
a far less pronounced effects than the ones obtained with the single chemicals, as the TBT 
and DEHP effects overcame the single effects of BPA. Moreover, only the mix with high 
non-environmentally-relevant concentrations (10x the environmentally-leveled mix of 10 
nmol/L BPA, 100 nmol/L DEHP and 1 nmol/L TBT) was able to result in an increase of 
adipogenesis and induce the expression of adipogenic marker genes. In either the mix with 
the highest concentrations, nor with the lowest concentrations, the triglyceride levels were 
changed, which was not expected considering the individual substances’ responses and 
the fact that adipogenesis was clearly enhanced at the highest concentrations tested. 
Lyche and collaborators (2013) exposed, through the diet, a parent generation (F0) of 
zebrafish to natural mixtures of persistent organic pollutants (POPs) extracted from the liver 
of burbot (Lota lota) from Lake Mjøsa and Lake Losna in Norway. The chemical analysis 
indicated the dominance of polybrominated diphenyl ethers (PBDEs), polychlorinated 
biphenyls (PCBs) and dichlorodiphenyltrichloroethane (DDT) metabolites in the Mjøsa 
Lake, whereas Lake Losna contained the same compounds yet with low levels of PBDEs. 
After performing a genome wide transcriptome profiling of the zebrafish 3rd-generation (F2) 
embryos and functional gene network analysis, they have noted that among the observed 
effects, carbohydrate and lipid metabolism were influenced by the exposure and identified 
the hepatocyte nuclear factor 4 alpha (HNF4A) as central regulators of the network (Lyche 
et al., 2013). The same environmental samples, which were chemically quantified and the 
concentrations of POPs fit the levels reported in human and wildlife populations, resulted in 
increased weight of the exposed zebrafish (from 6 dpf to 5 months) at the end of the 
exposure period, and central positions of the network obtained through microarrays were 
occupied by key regulators of weight (PPARs, glucocorticoids, C/EBPs, estradiol), steroid 
hormone functions (glucocorticoids and estradiol) and insulin signaling (HNF4A, C/EBPs 
and PPARγ) (Lyche et al., 2011). 
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In a study of exposure in the field, the Atlantic bluefin tuna (Thunnus thynnus) caught in 
the Strait of Messina in the central Mediterranean Sea, exhibited accumulation of PCBs 
(mostly dioxin-like PCBs) and organochlorine pesticides (OCPs) in the liver, more 
accentuated in males, concomitantly with an ectopic lipid accumulation in both sexes and 
high expression of PPARγ and RXRα genes (especially in males). Furthermore, a 
metabolomics approach indicated a significant hepatic glucose depletion from males to 
females, alongside an increase in levels of malonate, which indicate the occurrence of fatty 
acid biosynthesis in the liver. Once again, it was mentioned the possibility that the different 
accumulation pattern between sexes could be due to a lipid mobilization from the liver to 
the gonads to support egg development in females, and could also be attributed to less 
feeding during the reproductive period (Maisano et al., 2016). 
Sarotherodon melanotheron from a contaminated tropical freshwater dam (Awba Dam 
in Nigeria), rich in PCBs, OCPs, polycyclic aromatic hydrocarbons and heavy metals 
according to sediment samples chemical analysis, was compared to a reference site and it 
was described that the size of the contaminated fish was bigger and had higher levels of 
PPARα, β and γ mRNA levels in both sexes, although the PPAR protein levels were higher 
in the contaminated females in comparison to the contaminated males. The chemical 
concentrations found in the samples also correlated with the increase in the liver somatic 
index (Adeogun et al., 2016). 
In summary, it appears that the effects of some obesogens might be gender- and organ-
dependent (e.g. BPA affecting mostly males and the liver) and might not affect the different 
species through the same regulatory pathways, since some nuclear receptors, which play 
central roles in the maintenance of lipid homeostasis, have been reported to have structural 
differences in their ligand binding domain which could lead to distinct ligand-binding 
affinities among species (e.g. TBT with human and zebrafish PPARγ). Unveiling the 
crystallographic structure of TBT binding to the human RXR and PPARγ has allowed a 
better understanding of the mode of action and interaction of this obesogen with the 
receptors. Similar studies should be performed with other chemicals and nuclear receptors 
to help elucidate the eventual different responses of species exposure to a particular 
obesogen. 
As seen in our study, TBT does indeed increase in vivo lipid accumulation in Danio rerio, 
although no statistically significant differences in the studied transcripts compared to the 
control were detected and a significant repression of the RXR:PPARγ heterodimer in vitro 
was observed. Whether the zebrafish RXR:PPARγ regulates lipid homeostasis through its 
repression, instead of an activation as seen in the mammalian heterodimer, remains to be 
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investigated. Seeing that TBT activated the zebrafish RXR but repressed the heterodimer 
in vitro, it seems possible that other receptors forming heterodimers with RXR and that also 
play roles in the maintenance of the lipid homeostasis, such as the FXR and LXR, could be 
a more important vehicle for the observed effects of TBT in vivo in zebrafish, rather than the 
RXR:PPARγ heterodimer signaling pathway. 
These receptors are also tightly related to some of the genes studied here. LXR is 
involved in cholesterol homeostasis and regulates the expression of SREBP-1, while PXR 
regulates lipid homeostasis and the expression of PPARγ in the liver (Capitão et al., 2017). 
The interaction of chemicals with the RXR:PPARγ heterodimer is particularly 
concerning, not only as it may lead to lipid and glucose homeostasis perturbation but also 
due to the presence of PPARs in vertebrate and many invertebrate groups 
(Cephalochordates, Urochordates, molluscs and Echinoderms) and RXRs in most 
metazoans, which indicate that the taxonomic scope of this inappropriate regulation of the 
pathways is wider than initially expected (Lyssimachou et al., 2015; Santos et al., 2012). 
Moreover, RXR is the heterodimeric partner of several other nuclear receptor that are 
involved in lipid homeostasis to some extent [LXR (liver X receptor) and FXR (farnesoid X 
receptor) present in deuterostomes and the ecdysone receptor, a LXR/FXR orthologue in 
some protostomes], some of which also form permissive heterodimers (Capitão et al., 
2017). 
Taking together our findings along with the ones in previous studies, compiled evidence 
points to an impact of the surrounding environment in lipid homeostasis, not only in human 
beings but throughout the animal kingdom. Indeed, more than 1300 chemicals have been 
identified as potential endocrine disrupting chemicals, yet only a few have been tested in 
vivo, and within this group, very little is known about their ability to disrupt lipid homeostasis 
(Capitão et al., 2017). Being widely present in products of our daily life, with some examples 
including cosmetics, plastics, food cans and pesticide-treated food (Capitão et al., 2017), 
obesogens threaten not only the human populations worldwide, but also the environment 
and ecosystems. In worst cases, these compounds persist in the environment either due to 
their physicochemical properties, which can also lead to their bioaccumulation and 
biomagnification, or for the simple fact that they are continuously being released into the 
environment (Capitão et al., 2017). 
Our study focused on the interaction of suspected obesogens with the pre-translational 
transcriptional regulation of the lipogenic and adipogenic genes and enzymes, yet 
obesogens have been shown to have several possible modes of action beyond the ones 
included here. Post-translational regulation of certain enzymes, such as CPT1 (Guan et al., 
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2016) and ACC (Capitão et al., 2017; Wang et al., 2015) have been shown to modify their 
activity and affect the affinity for certain substrates (Guan et al., 2016), allowing a rapid 
regulation of lipogenic enzymes (Wang et al., 2015), therefore, it would be important to 
investigate whether obesogens and environmental samples are able to induce these 
modifications.  
Since developing organisms, such as fetuses and neonates, are the most sensitive to 
chemicals with hormone-like activity (Newbold et al., 2007), studying the effects of their 
exposure to these chemicals should be a priority. This particular sensitivity is due to the lack 
of fully functional protective mechanisms such as DNA reparations, an efficient immune 
system, good liver metabolism, detoxifying enzymes and a developed blood/brain barrier, 
therefore allowing toxic effects to occur at much lower concentrations of the chemical that 
the ones affecting the adult (Newbold et al., 2007). In some cases, it is possible that effects 
revealed in offspring are not detected in the exposed progenitors (Newbold et al., 2007), for 
example, obesogens affecting adipogenesis per se probably exert a higher impact during 
periods of adipose tissue differentiation (i.e. fetal development, perinatal nursing and 
adolescence) (Grün & Blumberg, 2009). Moreover, effects resulting from perinatal exposure 
may not manifest until later in life (e.g. adulthood) (Newbold et al., 2007), thus, it is important 
to examine the consequences of exposure to obesogens in developing organisms, both 
during the development and after reaching the adult stage, but also at a transgenerational 
level. 
So far, a few chemicals have been reported to cause obesity-related transgenerational 
effects in rats, such as plastic components (BPA, DEHP and dibutyl phthalate), a mixture 
of hydrocarbons, as well as DDT and possibly its primary metabolite 
dichlorodiphenyldichloroethylene (DDE, an anti-androgen) that has also been reported to 
lead to epigenetic modifications in sperm (Chamorro-Garcia & Blumberg, 2014). 
The zebrafish short life cycle and rapid maturation facilitate the experimentation for 
transgenerational endpoints, such as the study of epigenetics (Hill et al., 2005). Moreover, 
gene programming and development in early life stages (e.g. embryo) is conserved among 
vertebrates and transplacental transfer of chemicals to the offsprings in mammals is similar 
to the transmission of these chemicals from the female fish to the eggs (Hill et al., 2005), 
making the zebrafish a suitable model for these studies. 
Epigenetic alterations, such as DNA methylation, histone modifications or noncoding 
RNA, could be a potential target for obesogen action (Bašić et al., 2012; Biemann et al., 
2014), hence whether obesogens promote transgenerational obesogenic effects through 
interferences with epigenetic mechanisms should be an object of future research. 
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 In this regard, Manikkam and collaborators have exposed gestating Sprague Dawley 
female rats (generation F0) intraperitoneally and during embryonic days 8-14 of 
development, to a mixture of plastic derived compounds (BPA, DEHP and dibutyltin) and 
reported an epigenetic transgenerational inheritance of adult onset disease, from which 
obesity was one of the evaluated endpoints (Manikkam et al., 2013). The F3 generation 
sperm epigenome revealed 197 differential DNA methylation regions in gene promoters 
(epimutations), some of them with a direct connection in the gene network associated with 
the identified pathologies, more specifically, 5 of these genes correlated to known obesity-
related genes. Moreover, at the lowest doses (25 mg/kg BPA, 375 mg/kg DEHP and 33 
mg/Kg dibutyltin per day), both F3 males and females suffered an increase in body weight, 
as well as abdominal fat deposition and adiposity in most organs. 
Following a better understanding of the obesogens’ role in obesity, focus should be 
applied on uncovering prime targets for pharmaceutical intervention, as the traditional 
dietary approaches fail to combat obesity. For this purpose, a complete picture of the 
network of interactions within the cell and between organs needs to be obtained. The 
advances of the omics such as genomics and proteomics have provided new tools for the 
discovery of biomarkers of both exposure and effects of the action of chemicals, as they 
apply high-throughput techniques that allow the visualization and comparison of the full 
expression patterns of cells or tissues, following exposure to chemicals, to a control state, 
and could help identify genes and proteins, regulated by each nuclear receptor, that are 
altered by obesogen exposure, like a “fingerprint” (Benninghoff, 2007; Capitão et al., 2017). 
This “fingerprint” of exposure would aid in the prediction of the obesogen mode of action, 
although any sort of expression profile (gene and protein) is simply a snapshot of a highly 
dynamic system from which temporal changes can occur (Benninghoff, 2007). Proteomic 
approaches include two-dimensional gel electrophoresis (2DE) coupled with mass 
spectrometry (MS) for protein identification, matrix-assisted laser desorption ionization time-
of-flight mass spectrometry (MALDI-TOF-MS) and surface-enhanced laser desorption 
ionization time-of-flight mass spectrometry (SELDI-TOF-MS), that could be used to identify 
differentially expressed proteins (Benninghoff, 2007). 
Although PPAR activity could be pharmacologically controlled to treat metabolic 
disorders (Feige et al., 2007), it is important to remember the existence of adverse effects 
of previous potent PPARγ agonists (e.g. TZDs). Hence, the discovery of selective 
modulators that could provide the beneficial effects of the current agonists, without their 
side effects, is one of the challenges in pharmaceutical research (Feige et al., 2007). 
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To further elucidate the mechanisms of obesogen-mediated lipogenesis and 
adipogenesis, gene knockdown by morpholinos or other approaches such as CRISPR/Cas9 
and transient or stable transgene expression assays could be performed, with zebrafish 
remaining a popular model as it is easily genetically manipulated (Hill et al., 2005; Hölttä-
Vuori et al., 2010). Moreover, morpholinos or CRISPR/Cas9 targeting genes that are 
expressed differentially after exposure to an obesogen, could help prevent the toxicity of 
the latter (Hill et al., 2005). 
5. Conclusions 
New compounds are emerging as ligands of nuclear receptors related to metabolic 
pathways of lipid metabolism, which supports the idea of a link between obesity and 
environmental contamination. The combination of in vitro assays focused on the activation 
of PPARγ and other receptors essential for lipid homeostasis and adipogenesis, along with 
in vivo assays, allows the first line screening of obesogens, followed by an examination and 
confirmation of the existence of obesogenic effects in animals. Additionally, bioinformatics 
help to integrate information for a better understanding of the obesogens’ mode of action. 
The exact role of environmental contamination in the development of obesity and related 
disorders is not yet fully uncovered. Indeed, the studies evidencing the additive or 
synergetic effects of both exposure to obesogens and feeding with high-fat diets (e.g. egg 
yolk) are many and some reported a lack of obesogenic effects when in the absence of this 
type of diet. These observations seem to suggest that in the absence of a high-caloric 
intake, the effects of obesogens are either very low or non-existent. Nonetheless, since the 
changes in dietary habits towards high caloric intake are an issue in most countries, the 
simultaneous assessment of the effects of obesogens and overnutrition might represent the 
current status of human life more accurately. 
Furthermore, the many studies indicating the existence of a sexual dimorphism in the 
observed effects suggest that the genders should be evaluated separately. As different 
tissues and organs display distinct molecular responses following exposure to chemicals, 
organ-specific evaluations might be more informative than a whole-body assessment. 
Differences in the accumulation of chemicals between tissues might be the underlying 
cause for these differential responses. 
As reviewed by Hölttä-Vuori et al., (2010), the zebrafish is an attractive model in the 
study of lipid homeostasis, owning to a variety of advantages, among which the 
conservation of the mechanisms underlying lipid metabolism, between the zebrafish and 
mammals, play an important role. Hence, this species serves both for an assessment of the 
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effects of obesogens in the aquatic environment, as well as for the assessment of their 
effects on more complex animals, such as the humans. Regardless, we have concluded 
that the small differences among species can greatly influence the outcomes of exposure 
to obesogens, as it is the case of the structural differences between the LBDs of nuclear 
receptors which lead to distinct chemical binding specificities and affinities. 
Overall, the present study shows that environmental samples and model obesogen 
TBT, at environmentally relevant concentrations, are able to increase the lipid accumulation 
and interfere with the transcriptional regulation of lipid homeostasis of zebrafish in vivo, by 
interacting with the PPARγ:RXR heterodimer or the RXR receptor and modulating the 
expression of key enzymes from downstream pathways of the adipogenic/lipogenic 
cascade. 
Many of the presented studies, including ours, involved chemical concentrations found 
in the environment or human/animal blood and tissues. The most concerning cases are high 
levels of EDCs in either the cord blood or maternal milk, as they denote the presence of 
perinatal and early postnatal exposure within populations, which can be specifically 
hazardous during development, not only due to the lack of fully functional protective 
mechanisms, but also since some obesogens might bias undifferentiated cells towards the 
adipogenic lineage at the expense of other lineages (e.g. osteogenic). Therefore, studying 
the impact of early exposure in critical periods of the animal development and at a 
multigenerational and transgenerational level is essential to comprehend the true role of 
chemical exposure in the obesity epidemic. 
Additionally, future studies should focus on the more realistic scenarios of exposure, 
which can be achieved through the evaluation of the outcomes of exposure to chemical 
mixtures and chemically-characterized environmental samples, since studies on single 
obesogens do not reflect the possible additional, synergistic or antagonistic relationships 
that can be observed between compounds in the environment. 
The scientific community has become interested in the development of drugs that could 
decrease triglyceride synthesis and fat storage, in order to reduce adipose tissue mass and 
the transcription factors SREBP1 and PPARγ could indeed be attractive targets for 
pharmaceutical intervention, since they are differentially expressed after exposure to single 
obesogen chemicals and to mixtures. Our observations confirm that nuclear receptors could 
be targets of interest for the action of pharmaceuticals designed to treat obesity and related 
pathological conditions, however as these receptors take part in a variety of functions within 
the cells and tissues while commanding the expression of several genes, targeting them 
might lead to undesired outcomes, as it is the case with TZDs in diabetic patients. It is, 
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therefore, a priority to understand precisely what the consequences of targeting these 
receptors with new drugs are. Obtaining a complete picture of the network of interactions 
between genes or proteins within the organisms should be a major focus of the future 
research and could be facilitated through the application of the high-throughput omic 
techniques, which could potentially lead to the detection of a “fingerprint” of exposure and 
outcomes for obesogens. 
Thus, for our future work, investigating new metabolic pathways, other transcriptional 
regulation mechanisms, other genes, enzymes and hormones involved in the maintenance 
of lipid homeostasis and their upstream regulators (e.g. nuclear receptors, such as PXR 
and LXR, and transcription factors), will help elucidate the underlying molecular 
mechanisms of chemical-induced obesity, which will be crucial for the development of 
pharmaceuticals and therapies capable of curbing obesity and associated pathologies. 
Lastly, a full characterization of our WWTP samples will allow a better interpretation of the 
obtained results. 
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